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V. Summary 
Neutrophils play an important role in innate immunity by defending the host against invaded 
microorganisms. Antimicrobial activity of neutrophils is mediated by phagocytosis, release of 
reactive oxygen species and lytic enzymes as well as formation of neutrophil extracellular 
traps (NET). These structures are composed of DNA, histones and certain granular proteins 
such as neutrophil elastase as well as some cytoplasmic proteins. NET formation in different 
organisms, its bactericidal activity, and its presence in several pathophysiological conditions 
have been documented; however, little is known about the direct effect of NET on the host 
cells and its potential role in the pathogenesis of acute lung injury (ALI). This study aims to 
decipher the influence of NET on host cells, particularly alveolar epithelial cells as major 
cells responsible for gas exchange in the lung. 
Herein, NET formation was documented in the lung tissue and the bronchoalveolar lavage 
fluid in a mouse model of ALI. Upon direct interaction with epithelial and endothelial cells, 
NET induced cytotoxic effects in a dose-dependent manner, and digestion of DNA in NET 
did not change NET-mediated cytotoxicity, indicating that NET associated proteins are 
responsible for this effect. NET associated proteins were also identified by mass 
spectrometry. Following treatment of epithelial cells with NET, different proteins with roles 
in cell death processes were upregulated. Pre-incubation of NET with antibodies against 
histones significantly reduced NET-mediated cytotoxicity, suggesting that the cell-destructive 
activity of NET was at least in great part mediated by histones. Activated protein C (APC) 
did decrease the histones-induced cytotoxicity in a purified system, but did not change NET-
induced cytotoxicity, indicating that histones in NET are protected against APC degradation. 
Inhibition of neutrophil elastase, another abundant component of NET, did not decrease 
NET-mediated cytotoxicity, although elastase activity increased after DNA digestion. 
Inhibition of myeloperoxidase, another granular component of NET, decreased NET-
mediated cytotoxicity. Moreover, in epithelial cells, NET induced a biphasic change in 
cellular permeability; at earlier stages decrease and at the later stages increase was observed. 
These data reveal the important role of protein components in NET, particularly histones and 
partly myeloperoxidase, which may lead to host cell cytotoxicity and may be one of the 
inducers of organ destruction associated with inflammatory diseases including ALI. Thus, 
NET in a spatio-temporal manner can influence the cell functions.  
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VI. Zusammenfasung 
Neutrophile erfüllen eine wichtige Rolle bei der angeborenen Immunabwehr, indem sie in 
den Körper eindringende Mikroorganismen bekämpfen. Ihre antimikrobielle Aktivitität wird 
durch Phagozytose, die Ausschüttung reaktiver Sauerstoffspezies ("reactive oxygen species", 
ROS) und lytische Enzyme vermittelt. Eine alternative Bekämpfung der Pathogene kann über 
die Ausbildung von sogenannten "Neutrophil Extracellular Traps" (NET) erfolgen, einer 
speziellen Art des Zelltods, bei dem die Neutrophilen DNA, Histone, verschiedene granuläre 
Proteine (wie z.B. Neutrophile Elastase), aber auch zytoplasmatische Komponenten netzartig 
herausschleudern. Obwohl die Ausbildung von NET in verschiedenen Organismen und 
pathophysiologischen Bedingungen und ihre bakterizide Wirkung dokumentiert wurde, ist 
wenig bekannt über die Wirkung von NET auf körpereigene Zellen und im speziellen bei der 
Pathogenese des akuten Lungenschadens (ALI). In dieser Arbeit wurde die Auswirkung der 
NET-Bildung auf Endothel- und Epithelzellen studiert, vor allem im Bezug auf funktionelle 
Veränderungen von alveolären Epithelzellen, die mit für den Gasaustausch in der Lunge 
verantwortlich sind. 
In einem Mausmodell des ALI konnte die Bildung von NET in Lungengewebe und Lavage 
der erkrankten Tiere gezeigt werden. Direkte Interaktion von NET mit endothelialen und 
epithelialen Zellen führte nicht nur zu Änderungen in der Permeabilität des Zellverbandes, 
sondern auch zu einer erhöhten Synthese pro-apoptotischer Proteine und wirkte sich in 
konzentrationsabhängiger Weise zytotoxisch auf die Zellen aus. 
Da der DNase-Verdau von NET keinen Einfluss auf deren zytotoxischen Effekt hatte, können 
NET-assoziierte Proteine dafür verantwortlich gemacht werden. Hier waren es vor allem 
Histone, die auch in isolierter Form zytotoxisch wirkten, was durch verschiedene Antikörper 
gegen Histone verhindert werden konnte. Da aktiviertes Protein C (APC) Histone degradiert, 
wurde die Histon-induzierte Zytotoxizität in vitro reduziert, nicht aber die NET-induzierte 
Zytotoxizität. Dies legt den Schluss nahe, dass Histone in NET gegen den Abbau durch APC 
geschützt sind. Die Inhibierung von Neutrophiler Elastase, einem weiteren Proteinbestandteil 
von NET, hatte keine Wirkung auf deren Zytotoxizität, allerdings konnte eine stärkere 
Elastase-Aktivität nach DNase-Behandlung von NET festgestellt werden. Die Inhibierung 
von Myeloperoxidase, einer weiteren Komponente der NET verningerte allerdings die NET-
induzierte Zytotoxizität. Die Proteomanalyse von mit NET inkubierten Epithelzellen zeigte 
einen deutlichen Anstieg an Apoptose-relevanten Proteinen. 
Zusammenfasung 
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Diese Arbeit zeigt, dass bestimmte Proteine in den NET und hier vor allem die Histone, aber 
auch Myeloperoxidase stark zytotoxisch auf Endothel- und Epithelzellen wirken. Damit 
können NET einer der Auslöser für die Zerstörung von Geweben und Organen bei 
entzündlichen Erkrankungen, wie beispielsweise des akuten Lungenversagens (ALI), sein. 
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1 Introduction 
1.1 Immunity 
The ability to respond to foreign substances including microbes or macromolecules such as 
proteins or polysaccharides is called “immunity”. Defending against infectious microbes is 
the physiologic function of the immune system which includes “innate” and “adaptive” 
immunity. Early reaction of the immune system is mediated by innate immunity which 
consists of various immune cells, mediators secreted by these cells and the complement 
system. These cells and mediators are present even before infection and therefore respond 
within minutes and hours after exposure to a noxious stimulus. The main components of the 
innate immunity are (a) physical and chemical barriers, for instance skin or mucosal epithelia 
and the substances produced by the epithelia; (b) phagocytic cells (neutrophils and 
macrophages) and natural killer cells; (c) the complement system and (d) proteins called 
cytokines which regulate the activities of the innate immunity cells. Innate immunity differs 
from adaptive immunity so that adaptive immunity is activated only after exposure to 
infectious agents and gains specific immunity against distinct stimulus. In adaptive immunity 
“lymphocytes” and their products have the main role. Adaptive immunity includes “humoral” 
and “cell-mediated” immunity. Humoral immunity is mediated by blood molecules called 
“antibodies” which are produced by B-lymphocytes. Antibodies recognize specific microbial 
antigens and eradicate the target microbes by different functional mechanisms. T- 
lymphocytes are involved in cell-mediated immunity. Antibodies cannot reach intracellular 
microbes such as viruses and several bacteria and therefore cell-mediated immunity involves 
in defence against these types of infection by destroying the infected cells. In contrast to 
innate immunity, adaptive immunity has the ability to “remember” and create much stronger 
responses after facing a specific microbe and therefore it is considered more specific (Abbas 
and Lichtmann, 2003). 
Adaptive immunity uses several innate immunity mechanisms for obliteration of the 
microbes mostly by increasing the antimicrobial activities of the innate immunity system. For 
instance, some antibodies increase phagocytosis and other antibodies induce release of 
inflammatory mediators from the leukocytes. Recent studies show that cells and mediators in 
innate immunity can also regulate adaptive immunity and therefore innate immunity should 
not be considered as an ineffective and non-specific part of the immune system. In fact, 
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innate immunity can regulate and induce adaptive immunity in such a way which is more 
efficient for obliteration of infection (Kumar and Sharma, 2010).   
 
1.2 Neutrophils 
Polymorphonuclear neutrophils (neutrophils or PMN) are crucial cells of the innate immune 
system that form the first line of defense against bacteria and fungi (Borregaard and 
Cowland, 1997; Nathan, 2006). Neutrophils are a subgroup of granulocytes and the largest 
subpopulation of white blood cells. They differentiate in the bone marrow from hematopoetic 
stem cells to mature neutrophils. The differentiation starts from myeloblasts through 
promyelocytes to neutrophilic myelocytes and metamyelocytes. Neutrophils have a tri-
lobulated nucleus and contain abundant granules. Primary or azurophilic granules are formed 
in the promyelocyte stage, whereas the secondary or specific granules are formed in the 
myelocytic stage. Later, during the metamyelocyte stage tertiary granules are generated and 
secretory vesicles are produced by endocytosis when neutrophils are circulating in the blood 
stream (Borregaard et al., 1987). Approximately 300 different proteins are found in the 
neutrophils granules (Lominadze et al., 2005). Granules which are produced later in 
differentiation of neutrophils are released earlier during the recruitment of neutrophils from 
the bloodstream to the site of infection. Secretory vesicles are released immediately after 
establishment of contact between neutrophils and endothelium. Tertiary granules are released 
during the transmigration of neutrophils through endothelium and secondary and primary 
granules are released at the site of inflammation (Faurschou and Borregaard, 2003). 
 
1.2.1 Neutrophil granules  
1.2.1.1 Granules components 
Secretory vesicles, which originate from endocytosis, contain a collection of membrane-
associated receptors and will be integrated into the plasma membrane after the release of 
vesicles (Sengelov et al., 1993). Some of these receptors include formyl peptide receptors 
(fpr), β-2 integrins, CD14 and CD16 (Fc receptor) and CD10. Integration of these receptors 
on the PMN leads to interaction of neutrophils with the endothelium, dendritic cells and 
monocytes. Albumin and heparin binding protein (HBP or azurocidin or CAP37) are stored in 
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the matrix of secretory vesicles. HBP has an important role in increasing vascular 
permeabilty mediated by neutrophils (Tapper et al., 2002; Gautam et al., 2001). 
Tertiary or gelatinase granules are secreted more easily than secondary granules and contain 
matrix degrading enzymes (matrix metalloproteinase-9 and lysozyme) and membrane 
receptors (fpr and CD11b) required for PMN extravasation (Mollinedo et al., 1997). 
Secondary or specific granules are bigger than tertiary granules and contain antimicrobial 
proteins (lactoferrin, lysozyme and hCAP18, the proform of LL-37) which are used for 
antimicrobial activity in phagolysosome or exterior of the cells. The membrane proteins of 
the secondary granules include laminin receptor, vitronectin receptor, fpr and TNF receptor 
(Soehnlein et al., 2009). 
Primary or azurophilic granules contain several antimicrobial proteins while their membranes 
almost lack receptors. These granules contain myeloperoxidase (MPO), HBP, human 
neutrophil peptides 1-3 (HNP 1-3 or α-defensins) and different serine proteases such as 
elastase, cathepsin G and proteinase 3 (Rice et al., 1987; Sinha et al., 1987; Salvesen et al., 
1993; Campanelli  et al., 1990). 
1.2.1.2 Neutrophil granules and neutrophil-endothelial interaction 
PMN granules are safely stored within the PMN until they get activated by inflammatory 
stimuli, such as N-formyl-methionine containing peptides released by bacteria, complement 
products such as C5a and chemokines such as interleukin (IL)-8. Upon initiation of 
inflammation, PMN start to interact with the endothelium, resulting in the release of secretory 
vesicles. These constitute a pool of membrane-bound receptors that are integrated into the 
PMN plasma membrane (Fig. 1.1). A PMN rolling along the endothelium adheres to it and 
then both pattern recognition and chemokine receptors distinguish signals from the 
environment. Secretory vesicles are released at the luminal side when PMN establish an 
interaction with the endothelium, while exocytosis of tertiary granules is initiated upon PMN 
transendothelial migration. At this point, discharge of the metalloproteinases MMP-8 and 
MMP-9 most likely allows the PMN to cut its way through to the basement membrane. 
During the subsequent migration, PMN primary and secondary granules undergo partial 
exocytosis (Lacy and Eitzen, 2008; De Yang et al., 2000; Soehnlein et al., 2009).   
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1.  Free flow           2. Rolling (Crawling)         3. Adhesion           4. Transmigration          5. Migration 
 
 
 
 
Secretory vesicles 
 
Tertiary granules 
 
Secondary and primary granules 
Membrane 
FPR, β2- integrins, CD16, 
CD14, proteinase-3 
FPR, β-2 integrins, 
TNF-R 
Laminin-R, FPR, TNF-R, CD63, CD66 
Matrix Azurocidin, albumin 
MMP-9, lysozyme, 
arginase 
Collagenase, LL-37, HNP1-3, 
azurocidin, cathepsin G, elastase, MPO, 
proteinase-3 
 
Figure 1.1: Granule subsets are released at different stages of PMN extravasation. PMN migrate from the 
vessel through a series of cell–cell and cell– matrix interactions. Granule subsets are released at different steps 
of PMN extravasation. Release of secretory vesicles following PMN adhesion leads to the deposition of PMN 
on the endothelial cell surface and integration of receptors (CD14, CD16, β2-integrins) into the PMN cell 
surface. Transmigrating PMN release tertiary granules, which contain proteases to help penetration of the 
basement membrane. The migrated PMN deposit proteases (e.g. cathepsin G, elastase) and antimicrobial 
polypeptides (e.g. LL-37, azurocidin, HNPs) in the extravascular tissue, leading to interaction with nearby cells. 
Abbreviations: FPR, formyl peptide receptor; HNP, human neutrophil peptide; MMP-9, matrix 
metalloproteinase 9; MPO, myeloperoxidase; TNF-R, tumor necrosis factor receptor (Soehnlein et al., 2009 
with modifications). 
 
This first recruitment and extravasation of PMN into the inflamed tissue is further replaced 
by mononuclear leukocytes (monocytes and lymphocytes) and macrophages. PMN granules 
have an essential role in recruitment of monocytes to the inflamed tissue by directly inducing 
monocyte adhesion to the endothelial cells, increasing the expression of adhesion molecules 
on the endothelial cell surface and elevating the expression of chemokines which regulate the 
recruitment of leukocytes (Rebuck and Crowley, 1955; Soehnlein et al., 2009). 
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1.3 Mechanism of neutrophil bacterial killing 
1.3.1 Phagocytosis: an intracellular killing mechanism 
PMN have a variety of pattern recognition receptors (PRRs) such as Toll-like receptor (TLR) 
which recognize wide molecular patterns called PAMPs (pathogen associated molecular 
patterns) on infectious agents. Binding of infectious agents via TLRs results in phagocytosis 
and release of inflammatory cytokines (IL-1, TNF-alpha and IL-6) by PMN. Moreover, 
bacteria with IgG antibody on their surface have the Fc region exposed and this part of the Ig 
molecule can bind to the receptor on phagocytes. Binding to the Fc receptor requires prior 
interaction of the antibody with an antigen. Binding of IgG-coated bacteria to Fc receptors 
results in enhanced phagocytosis (Hickey and Kubes, 2009). Besides PRRs and Fc receptors, 
phagocytic cells have a receptor for the third component of the complement system, C3b. 
Binding of C3b-coated bacteria to this receptor also results in enhanced phagocytosis and 
stimulation of the respiratory burst (Fig. 1.2). 
At the site of infection, neutrophils engulf microbes. Phagosomes, the vesicles containing the 
pathogen, fuse with primary and secondary neutrophil granules. The antimicrobial contents of 
these neutrophil granules are released into the lumen of the phagosome, which is then called 
phagolysosome. In the phagolysosome the pathogens are killed after exposure to reactive 
oxygen species (ROS), enzymes, and antimicrobial peptides. 
In the phagolysosome, antimicrobial peptides and proteins such as defensins, 
bactericidal/permeability-increasing protein and the enzyme lysozyme, mainly function by 
disrupting the anionic bacterial surfaces. Proteases, such as neutrophil elastase and cathepsin 
G, degrade bacterial proteins, including virulence factors. Moreover, the NADPH oxidase 
complex assembles at the phagosomal membrane and produces O2 radical, which is converted 
to hydrogen peroxide by the enzyme superoxide dismutase. Hydrogen peroxide is then 
converted to hyperchlorous acid (HOCl) by MPO. HOCl seems to play a role in bacterial 
killing. The combination of antimicrobials and ROS kill phagocytosed bacteria (Hampton et 
al., 1998; Chapman et al., 2002; Mayer-Scholl et al., 2004; Hickey and Kubes, 2009).  
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Figure 1.2: Neutrophil phagocytosis of bacteria. Neutrophils express various receptors that assist bacterial 
phagocytosis, including macrophage receptor 1 (Mac1; also known as αMβ2 integrin and CR3), which binds 
complement component 3b (C3b) on the surface of opsonized bacteria. Neutrophils also express Fc receptors for 
IgG (FcγR), which enable binding of IgG-coated particles. These molecules aid the uptake of bacteria into 
membrane-bound compartments, known as phagosomes. Phagosomes subsequently fuse with lysosomes and 
neutrophil granules, which contain a wide range of proteolytic and antibacterial enzymes and peptides, thereby 
forming phagolysosomes. The azurophil (primary), specific (secondary) and gelatinase (tertiary) granules 
contain characteristic proteases, antimicrobial proteins and peptides, and enzymes. NADPH oxidase complex 
assembles at the phagosomal membrane and produces O2⎯, which is rapidly converted to hydrogen peroxide and 
together with various enzymes such as myeloperoxidase, result in the production of further potent oxidants that 
destroy the bacteria. BPI: bactericidal/permeability-increasing protein (Hickey and Kubes, 2009 with 
modifications). 
 
1.3.2 Neutrophil extracellular traps (NET): an extracellular killing mechanism  
Recently, another antimicrobial mechanism of neutrophils was described. Activated 
neutrophils eradicate microorganisms in the extracellular space by a process which is called 
neutrophil extracellular traps (NET) formation (Brinkmann et al., 2004). NET formation is an 
active process; upon activation of neutrophils e.g. by IL-8,  the protein kinase C activator 
phorbol myristate acetate (PMA), lipopolysaccharide (LPS), gram positive and negative 
bacteria, fungi or activated platelets the chromatin de-condenses and hetero- and euchromatin 
are mixed. Later, the nuclear envelope and the granule membranes disintegrate and NET 
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components which are mainly chromatin and granular proteins are combined. Finally, the cell 
membrane is ruptured and NET are expelled from the cell (Fig. 1.3).  
 
Figure 1.3: Neutrophil extracellular traps (NET) formation. (A) Fluorescent micrographs showing the steps 
of NET formation. DNA is shown in red and granules are in green. (B) Activation of neutrophil leads to the 
formation of reactive oxygen species (step 1). The nuclear membranes start to disintegrate into vesicles and the 
integrity of the granules is lost (step 2). Nuclei then lose their lobules and mix with the contents of the granules 
(step 3). During the final stage, the cells round up, contract and finally expel NET (step 4). (C) A transmission 
electron micrograph of a neutrophil at step 2 in the process. The arrows show the disintegration of the nuclear 
membrane, which allows the karyoplasms to mix with the cytoplasm (Brinkmann and Zychlinsky, 2007). 
 
NET formation is a “beneficial suicide” of neutrophils; these structures can trap 
microorganisms, prevent their invasion and by providing a high local concentration of 
antimicrobial peptides, they facilitate the antimicrobial activity of neutrophils (Brinkmann 
and Zychlinsky, 2007; Fuchs et al., 2007; Clark et al., 2007). 
Chromatin is considered the backbone of these structures, as NET can be degraded by 
DNases but not by proteases. Interestingly, several Gram-positive pathogens secrete DNases 
or have DNases bound to their cell wall, and these bacteria are more pathogenic. Strains of 
A 
B 
C 
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group A Streptococcus (GAS) that did not secrete DNases were significantly less pathogenic 
than the isogenic wild-type strains which secrete DNase, and degradation of NET by secreted 
DNase increases the virulence of DNase-positive strains. DNase-expressing strains of GAS 
and S. pneumoniae can escape killing by NET and are thus more pathogenic than strains 
without DNases (Sumby et al., 2005; Buchanan et al., 2006). Moreover, the expression of a 
positively charged capsule in S. pneumoniae reduces binding to the NET, and could therefore 
be one mechanism that bacteria use to avoid getting trapped in NET (Wartha et al., 2007). 
It seems reasonable that NET formation is a common mechanism of the innate immune 
system in vertebrates, as it has been observed in humans (Brinkmann et al., 2004; Gupta et 
al., 2005; Marcos et al., 2010), mice (Sumby et al., 2005; Buchanan et al., 2006; Wartha et 
al., 2007), rabbits (Brinkmann et al., 2004), horses (Alghamdi and Foster, 2005), cows 
(Lippolis et al., 2006) and fish (Palić et al., 2007). Interestingly, NET-like structures were 
also found in the hemolymph of insects and it was shown that they have a role both in innate 
immunity and hemolymph coagulation of the insects (Altincicek et al., 2007). Recently, it has 
also been demonstrated that the neutrophil serine proteases and extracellular nucleosomes 
enhance coagulation in liver microvessels and reduce bacterial invasion into tissue (Massberg 
et al., 2010). Therefore, NET and extracellular nucleic acids probably promote host survival 
by improving defense mechanisms against pathogens at sites of tissue damage/infection in 
both insects and mammals. Furthermore, extracellular structures similar to the extracellular 
traps described for neutrophils have been shown for mast cells and eosinophils which are 
called extracellular traps (ET) (Yousefi et al., 2007; von Köckritz-Blickwede et al., 2008). 
Activated eosinophils can release mitochondrial DNA in a reactive oxygen species-dependent 
manner, but independent of eosinophil death. In the extracellular space, the mitochondrial 
DNA and the granule proteins form extracellular structures able to bind and kill bacteria both 
in vitro and under inflammatory conditions in vivo.  
NETs contain not only nuclear and granular proteins but also cytoplasmic proteins including 
cytoskeletal and peroxisomal proteins and glycolytic enzymes. Urban and co-workers 
identified and quantified the composition of NET by proteome approach which is 
summarized in table 1.1. 
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Table 1.1 Identified NET proteins 
Cellular localization Protein name 
Granules Leukocyte elastase 
 Lactotransferrin 
 Azurocidin 
 Cathepsin G 
 Myeloperoxidase 
 Leukocyte proteinase 3 
 Lysozyme C 
 Neutrophil defensin 1 and 3 
Nucleus Histone H2A 
 Histone H2B: a) Histone H2B  b) Histone H2B like 
 Histone H3 
 Histone H4 
 Myeloid cell nuclear differentiation antigen 
Cytoplasm S100 calcium binding protein A8 
 S100 calcium binding protein A9 
 S100 calcium binding protein A12 
        Glycolytic enzymes Alpha-enolase 
 Transketolase 
        Cytoskeleton Actin (β and/or γ) 
 Myosin-9 
 Alpha-actinin (1 and/or -4) 
 Plastin-2 
 Cytokeratin-10 
          Peroxisomes Catalase 
 
Proteins that localize to NETs. Proteins are organized by their localization in unstimulated neutrophils       
(Urban et al. 2009 with modifications). 
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1.3.2.1 Mechanism of neutrophil extracellular trap formation 
NET can be generated after three hours stimulation with potent inducer of NET, PMA. 
Papayannopoulos and Zychlinsky have been proposed that neutrophils use three major 
strategies to fight and clear microbes: phagocytosis, degranulation, and NET formation and 
these strategies operate over different timescales (Fig. 1.4) (Papayannopoulos and 
Zychlinsky, 2009). However, Clark and colleagues have found that NET are made only 
minutes after activation by stimulated platelets under flow (Clark et al., 2007). Recently, a 
novel mechanism of rapid NET formation in response to Staphylococcus aureus has been 
described which happens very rapidly (5-60 min) and is oxidant-independent (Pilsczek et al., 
2010).  
 
Figure 1.4: The antimicrobial strategies of neutrophils. Neutrophils use three main strategies to fight and 
clear microbes: phagocytosis, degranulation, and NET formation. These strategies function over different 
timescales. Red: microbe, Blue: granular proteins in the phagolysosome, extracellular space, or tethered within 
the NET, Gray: decondensed DNA of the NET. Abbreviations: Hs, histones; MPO, myeloperoxidase; NE, 
neutrophil elastase (Papayannopoulos and Zychlinsky, 2009 with modifications). 
 
The process of NET formation is different from both apoptosis and necrosis. In necrosis, the 
nuclei of necrotic cells lose the segregation between eu- and heterochromatin inside an intact 
nuclear envelope. Apoptotic nuclei show condensed chromatin and are separated into several 
membrane-bound apoptotic bodies. By contrast, during NET formation, activated neutrophils 
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gradually dissolve their nuclear membranes and the granules, thus allowing mixing of NET 
components in the cytoplasm. In addition, the cell death that leads to NET formation is not 
accompanied by DNA fragmentation and does not require apoptosis-specific caspases. 
Moreover, NET formation is not the result of a direct disruption of the cell membrane; the 
situation which occurs when cells are attacked by bacterial toxins. It was shown that during 
the process of NET formation, neutrophils are alive before the NET are explelled from the 
cells (Fuchs et al., 2007).  
It was demonstrated that NET formation is dependent on the generation of ROS by NADPH 
oxidase and NADPH oxidase inhibitor, diphenylene iodonium, can block the formation of 
NET.  Moreover, neutrophils isolated from patients suffering from chronic granulomatous 
disease (CGD) fail to make NET when stimulated with either bacteria or PMA, that is, when 
stimulated upstream of NADPH oxidase. CGD patients carry mutations in one of the subunits 
of NADPH oxidase and suffer from catastrophic infections. These neutrophils do make NET 
when they are stimulated downstream of NADPH oxidase with hydrogen peroxide 
(Heyworth et al., 2003; Fuchs et al., 2007). However, neutrophils from neonate infants are 
not able to form NET even if they are stimulated downstream of NADPH oxidase (Yost et 
al., 2009). Remijsen and co-workers have recently shown that NET formation needs both 
autophagy and superoxide generation, and inhibition of either autophagy or NADPH oxidase 
activity prevents NET formation and leads to neutrophil cell death by apoptosis (Remijsen et 
al., 2010). Furthermore, Li and co-workers showed that histone hypercitrullination catalyzed 
by peptidylarginine deiminase 4 is essential for chromatin decondensation during NET 
formation (Li et al., 2010). Recently, Papayannopoulos and co-workers have shown that 
neutrophil elastase and MPO are necessary for regulation of NET formation. They showed 
that first elastase escapes from azurophilic granules and translocates to the nucleus, degrades 
specific histones and promote chromatin decondensation. Later, MPO, independent of its 
enzymatic activity, synergizes with elastase in chromatin decondensation (Papayannopoulos 
et al., 2010). Moreover, using a new chemical genetic analysis Hakkim and co-workers have 
shown that the Raf-MEK-ERK pathway is involved in NET formation by activation of 
NADPH oxidase and upregulation of antiapoptotic proteins (Hakkim et al., 2011). Therefore, 
NET formation seems to originate from the activation of different signaling pathways and 
cellular processes. 
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1.4 The role of neutrophils in inflammation 
Inflammation is a multifaceted set of interactions between the cells and soluble factors that 
can occur in any tissue in response to infectious, traumatic, post-ischaemic, toxic or 
autoimmune injury. This procedure usually leads to healing and recovery from infection; 
however, if destruction and repair are not accurately phased, inflammation can lead to 
constant tissue damage by cells such as leukocytes and lymphocytes (Nathan, 2002).  
Neutrophils as one of the body's major cellular components for the destruction of 
microorganisms also damages tissue and cells of the host. Neutrophil-mediated tissue damage 
at the infected sites is one of the major sources that launch inflammation, which in turn 
induces immunity. In fact, a normal immune response results from the ongoing detection of 
signals that report injury and signals that report infection.  Neutrophils make essential 
contributions to the recruitment, activation and programming of dendritic cells and 
macrophages. In turn, the adaptive immune system controls the rate of neutrophil production 
in the bone marrow (Nathan, 2006). 
 
Figure 1.5: The role of neutrophils in wound healing. The picture demonstrates one pathway out of many that 
are functioning in wounds. Neutrophil- and macrophage-derived secretory leukocyte protease inhibitor (SLPI) 
blocks neutrophil elastase. SLPI alone, and in synergistic combination with macrophage- and epithelial-cell-
derived proepithelin (PEPI), blocks cytokine-induced release of proteolytic enzymes and reactive oxygen 
intermediates (ROIs) by neutrophils. These actions decrease the neutrophil-dependent proteolytic conversion of 
PEPI to epithelins (EPIs), declining the ability of EPI to promote epithelial-cell production of CXC-chemokine 
ligand 8 (CXCL8; also known as IL-8), an important neutrophil chemoattractant. Intact PEPI promotes 
epithelial-cell proliferation, accelerating closure of the wound. Black arrows indicate processes involved in 
tissue repair and regeneration. Gray arrows indicate processes involved in host defence (Nathan, 2006). 
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Neutrophils also have significant roles in wound healing (Fig. 1.5).  The main role of 
neutrophils to wound healing is microbial sterilization. Wounds tend to heal weakly in 
individuals with inadequate neutrophils. Neutrophils contribute in wound healing by 
production of signals that decrease the rate of accumulation of more neutrophils, suppressing 
their own activation and by initiation of a macrophage-based program that switches the state 
of damaged epithelium from pro-inflammatory and nonreplicative, to anti-inflammatory and 
replicative (Nathan, 2006). 
Two of the most important mechanisms of damage by neutrophils are the respiratory burst 
and the degranulation response (Fig. 1.6). ROS and granular proteins can demolish 
microorganisms or their products; however, long exposure or high concentrations of these 
mediators can be detrimental for the host and lead to tissue injury (Nathan, 2006; Singer and 
Clark, 1999). 
Excessive inflammation has a main role in different diseases such as rheumatoid arthritis, 
osteoarthritis, chronic obstructive pulmonary disease (COPD) and multiple sclerosis. The 
usual goal of neutrophil-targeted pharmacology is not to increase inflammation but is to 
suppress it. Unfortunately, common approaches to neutrophil-based anti-inflammatory 
therapy have their own disadvantages since suppressing neutrophil migration or activities 
impair host defence against infection (Nathan, 2006). 
  
Figure 1.6: Anti-microbial activity with tissue destruction cross-talk in neutrophils. Two of the most 
important machansims of destruction by neutrophils are the respiratory burst and the degranulation response. 
Both can lead to bacterial killing and tissue damage. AP1, activator protein 1; ROI, reactive oxygen 
intermediates; H2O2, hydrogen peroxide; HOCl, hypochlorous acid; MMP, matrix metalloproteinase; O2-, 
superoxide; O3, ozone; .OH, hydroxyl radical; NF-kappaB; nuclear factor-kappaB (Nathan, 2006). 
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1.4.1 NET and inflammation 
NET have also been seen in vivo in experimental model of dysentery and human appendicitis 
samples (Brinkmann et al., 2004).  During severe sepsis, platelets via TLR-4 bind to 
sequestered neutrophils, leading to NET formation within minutes which trap the bacteria 
present in the systemic circulation but this also causes endothelial cell and hepatic damage 
(Clark et al., 2007).  
Neutrophils isolated from patients suffering from CGD are not able to form an effective NET 
(Fuchs et al., 2007). In vitro, Neutrophils of CGD patients are not capable to kill Aspergillus 
nudilans but gene therapy in these patients restored NET formation and resulted in recovery 
from Aspergillosis (Bianchi et al., 2009).  
Moreover, NET formation occurs in autoinflammatory disorders in the absence of microbial 
infection. In small-vessel vasculitis (SVV), which is a chronic autoinflammatory disease and 
linked to antineutrophil cytoplasm autoantibodies, NET deposit in inflamed kidneys and 
triggers vasculitis and promotes the autoimmune response against neutrophil components in 
individuals with SVV (Kessenbrock et al., 2009). Furthermore, patients with systemic lupus 
erythematosis (SLE) have autoantibodies against NET proteins as well as against dsDNA. A 
subset of SLE patients’ sera degraded NET poorly. These patients have either DNase1 
inhibitors or anti-NET antibodies which prevented DNase1 access to NET and it was shown 
that impairment in NET degradation is associated with lupus nephritis (Hakkim et al., 2010).  
ET, which are released by eosinophils, contain mitochondrial DNA as well as eosinophil 
granular proteins. Theses extracellular structures are able to bind and kill bacteria and were 
also found in colon samples of patients with Crohns disease (Yousefi et al., 2008). 
Fuchs and co-workers have recently shown that NET can induce thrombosis by stimulating 
platelets in vitro, and NET components were abundant in thrombi induced in baboons 
subjected to deep vein thrombosis, an example of inflammation-enhanced thrombosis (Fuchs 
et al., 2010). All of these examples show a potential proinflammatory role of NET. 
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1.5 Inflammatory lung diseases 
Inflammatory lung diseases refer to a group of diseases associated with different types and 
degrees of inflammatory cell accumulation in the lungs (Table 1.2). Diseases typically 
included in this group are acute lung injury/acute respiratory distress syndrome (ALI/ARDS), 
idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP), collagen vascular 
disease-associated interstitial pneumonia, nonspecific interstitial pneumonia, cryptogenic 
organizing pneumonia/bronchiolitis obliterans organizing pneumonia, sarcoidosis, 
hypersensitivity pneumonitis/extrinsic allergic alveolitis, and eosinophilic pneumonia. In a 
broad sense, COPD, bronchial asthma, and infectious diseases can also be included in this list 
(Fujishima, 2011). 
 
Table 1.2 Clinical course and inflammatory cells in inflammatory lung diseases 
Diseases Clinical course Major inflammatory cells observed 
Acute lung injury / Acute 
respiratory distress syndrome 
(ALI/ARDS) 
Acute Neutrophils 
Idiopathic pulmonary fibrosis / 
Usual interstitial pneumonia 
(IPF/UIP) 
Chronic / acute exacerbation Alveolar macrophages, neutrophils? 
Hypersensitivity pneumonitis (HP) Acute / chronic CD8 lymphocytes, (CD4 lymphocytes) 
Sarcoidosis Chronic CD4 lymphocytes 
Eosinophilic pneumonia (EP) Acute / chronic Eosinophils 
Chronic obstructive pulmonary 
disease (COPD) 
Chronic / acute exacerbation CD8 lymphocytes/ neutrophils 
Asthma Chronic / acute attack Eosinophils, basophils, Th2 lymphocytes 
 
Different inflammatory lung diseases, the clinical course and the major inflammatory cells which are involved 
in each disease (Fujishima, 2011). 
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1.5.1 Neutrophils and ALI 
ALI and its more severe form ARDS represent a form of lung dysfunction characterized by 
impairment in the functions of the alveolar-capillary barrier, hypoxemia, non cardiogenic 
pulmonary edema, low lung compliance and widespread capillary leakage. They result from 
complex responses of the lung to a multitude of direct and indirect insults, any stimulus of 
local or systemic inflammation, principally sepsis (Kollef and Schuster, 1995; Bernard, 1994; 
Wheeler and Bernard, 2007). Alveolar epithelial cell function and barrier integrity are crucial 
to preserve normal gas exchange, and injury or loss of epithelial cells leads to progression of 
ALI/ARDS (Ware and Matthay, 2000; Manicone, 2009). Although its pathogenesis is largely 
uncertain, neutrophil-dominant acute inflammation and resultant tissue destruction are the 
main pathological features. Since ALI/ARDS carries high mortality rates between 40 and 
60% (Rubenfeld et al., 2005), understanding of the mechanisms in the development of 
ALI/ARDS is essential for developing novel therapeutic options to treat these patients (Liu, 
2005; Liu and Slutsky, 1997). 
Acute inflammation features neutrophil accumulation and plasma exudates outside of the 
blood vessels. Neutrophil recruitment is directed by the lung cells. Adhesion molecules 
induced on the lung cells and chemokines and colony-stimulating factors from lung cells 
stimulate neutrophil production from the bone marrow and chemotaxis (Christopher and 
Link, 2007; Mizgerd, 2002; Mizgerd, 2008). Moreover, intratracheal administration of 
bacterial toxin such as pneumococcal virulence factor pneumolysin into the lungs of mice 
draws the alveolar accumulation of neutrophils (Maus et al., 2007). When neutrophils reach 
the site of infection, they generate proinflammatory signals, including TNF-α, IL-1 and 
chemokines which recruit and activate dendritic cells, monocytes, B-lymphocyte and T-
lymphocytes. Therefore, adaptive and innate immune responses against microbes in the lungs 
are shaped by signals derived from neutrophils (Mizgerd, 2008; Tateda et al., 2001; Liang et 
al., 2006).  
Moreover, after recruitment to the inflammatory site, neutrophils apply a variety of functions 
including production of ROS, phagocytosis, and degranulation of lytic enzymes that enable 
clearance of the invading pathogen. However, excessive inflammation and increased 
activation of neutrophils leads to injury and organ damage (Burns et al., 2003; Nathan, 2006). 
Neutrophil accumulation has been observed in lung tissue (Bachofen and Weibel, 1977; 
Bachofen and Weibel, 1982) and broncho-alveolar lavage (BAL) fluids of ARDS patients 
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(Pittet et al., 1997). Therefore, the recruitment and activation of neutrophils are considered 
crucial to the pathogenesis of ALI. Activated neutrophils contribute to lung injury by 
releasing proteolytic enzymes, ROS and other proinflammatory mediators (Lee et al., 2005; 
Abraham, 2003) and lung epithelial cell death represents a potentially important mechanism 
contributing to the loss of this cell type in the development of ALI (Perl et al., 2008; 
Bachofen and Weibel, 1982).  It has been shown that in different models of ALI depletion of 
neutrophils leads to decrease injury associated with ALI (Lomas-Neira et al., 2006; Inoue et 
al., 1995; Clark et al., 2003; Looney et al., 2006; Abraham et al., 2000).  
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2 Aim of the study 
Since high amounts of NET seem to be associated with pathophysiological conditions, it was 
hypothesized that neutrophil derived NET, in excessive amounts, may contribute to epithelial 
and endothelial cell death and injury in the pulmonary system.  
Thus the aims were: 
 To identify the protein components of NET by mass spectrometry; identification of NET 
components will give a better understanding of the function of NET. 
 To investigate NET formation in lung tissue and BAL fluid in the established animal 
model of LPS-induced acute lung injury; recognition of the precence of NET in the lung 
injury model may explain the deleterious role of NET.   
 To analyze, qualify and quantify NET in mice and human neutrophils; evaluation of NET 
is a key factor to compare the effect of different stimuli on NET formation.  
 To investigate the effect of extracellular adherence protein of Staphylococcus aureus in 
NET formation; the interaction between neutrophils and S. aureus in respect of NET 
formation has been described. However, the effect of extracellular adherence protein of S. 
aureus on NET formation has not been reported. 
 To study the direct effect of NET on endothelial and lung epithelial cytotoxicity and cell 
death; to this point, the direct effect of NET on host cells has not been documented.  
 To fractionate NET in order to analyze the cytotoxic components of NET; fractionation of 
NET, based on the molecular weight, will make the analysis of NET easier.  
 To examine the effect of separate components of NET on epithelial and endothelial 
cytotoxicity; analyzing the effect of NET conponents, particularly histones as major 
components of NET as well as elastase and myeloperoxidase, will reflect which factors in 
NET are responsible for the cytotoxicity. 
 To analyze the proteomic profile of epithelial cells after treatment with NET; proteome 
analysis of host cells after incubation with NET will clarify how they react to NET.  
 To study the effect of NET on epithelial permeability; change in cellular permeability 
after treatment with NET will elucidate one of the host cell responses to NET. 
 To investigate the presence of NET in cystic fibrosis patients; presence of NET in cystic 
fibrosis sputum implies the injourous role of NET in these patients and their 
complications. 
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3 Material and methods 
3.1 Materials 
3.1.1 Reagents 
 
2.5-dihydroxybenzoic acid (Sigma-Aldrich, Germany) 
2D-Quant kit (GE Healthcare, Germany) 
A549-human lung adenocarcinoma cell line (ATCC, USA) 
Acetone (Roth, Germany) 
Acrylamide-Bisacrylamide (Roth, Germany) 
Activated protein C (APC) (Xigris, Eli Lilly) 
Alexa Fluor 488 donkey anti-rabbit IgG (Invitrogen, Germany) 
Alexa Fluor 546 Monoclonal Antibody Labeling Kit (Invitrogen, Germany) 
Alexa Fluor 555 donkey anti-mouse IgG (Invitrogen, Germany) 
Amicon ultra-4 centrifugal filter units (Millipore, Germany) 
Ammonium persulphate (Roth, Germany) 
Anti-caspase-3 antibody (Cell Signaling Technology, Germany) 
Anti-CD46 (Santa Cruz, Germany) 
Anti-CD66b (Antibody-online, Germany) 
Anti-DNA Histone H1 (Millipore, Germany)  
Anti-Ly-6G MicroBead (Miltenyi Biotec, Germany) 
Anti-neutrophil elastase (M-18); goat polyclonal (Santa Cruz, Germany) 
Anti-neutrophil elastase; rabbit polyclonal (Calbiochem, Germany) 
Anti–β-actin antibody, clone AC-15 (Sigma Aldrich, Germany) 
Apoptotic/Necrotic/Healthy cells detection kit (PromoKine, Germany) 
Bovine serum albumin (Sigma-Aldrich, Germany) 
Bromophenol blue (Roth, Germany) 
Calcium chloride (Roth, Germany) 
CHAPS (GE Healthcare, Germany) 
Collagen I (BD Biosciences, Germany) 
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Coomassie Brilliant Blue R-250 (Serva electrophoresis, Germany) 
Cy2, 3 and 5 (GE Healthcare, Germany) 
Cytotoxicity detection kit (Roche Applied Science, Germany) 
DAPI (Vectashield mounting medium with DAPI, USA) 
Dimethylsulfoxide (Roth, Germany)  
DL-Dithiothreitol (DTT) (Sigma-Aldrich, Germany) 
DNase I, RNase free (Fermentas, Germany) 
Dulbecco’s modified Eagle medium (DMEM) (GIBCO-Invitrogen, Germany) 
ECL plus western blotting detection system (GE healthcare, Germany) 
Ethanol (Roth, Germany) 
Eythelene diamino tetra acetic acid (EDTA) (Roth, Germany) 
Fetal bovine serum (GIBCO-Invitrogen, Germany) 
FITC rat anti-mouse Ly-6G and LY-6C (BD Pharmingen, Germany) 
FITC rat IgG2b (BD Pharmingen, Germany) 
Flamingo fluorescent gel stain (Bio-Rad, Germany) 
Green multi-caspase staining kit (Promokine, Germany) 
HBSS (GIBCO-Invitrogen, Germany)  
HEPES (PPA, Germany) 
Histone H2A antibody (Cell signaling, Germany) 
Histone H2B antibody (Millipore, Germany) 
Histone H3 (citrulline 2 + 8 + 17) antibody [CitH3] (Abcam, Germany) 
Histone H3 antibody (Millipore, Germany)  
Histone H4 antibody (Cell signalling, Germany) 
Histone type IIA from calf (Sigma-Aldrich, Germany) 
Histopaque-1077 (Sigma-Aldrich, Germany) 
Histopaque-1119 (Sigma-Aldrich, Germany) 
HRP-conjugated anti-goat (Dako Cytomation, Denmark) 
Human neutrophil elastase (Serva electrophoresis, Germany) 
Human neutrophils (Primary, isolated)  
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Human Serum Albumin (Behring, Germany) 
Human umbilical vein endothelial cells (HUVEC) (Primary, isolated) 
Hybond-C polyvinylidene difluoride (PDVF) membrane (GE Healthcare, Germany) 
IPG-strips (Bio-Rad, Germany) 
LoBind tubes (Eppendorf, Germany) 
LPS; L4391 (Sigma-Aldrich, Germany) 
Methylendiphosphonic acid (Fluka, Germany) 
Micro-BCA protein assay reagent kit (Pierce, Germany) 
Micrococcal nuclease from Staphylococcus aureus (MNase) (Sigma-Aldrich, Germany) 
Mouse IgG isotype antibody; M4509 (Sigma -Aldrich, Germany) 
N-(Methoxysuccinyl)-Ala-Ala-Pro-Val 4-nitroanilide (Sigma-Aldrich, Germany) 
N-(Methoxysuccinyl)-Ala-Ala-Pro-Val-chloromethyl ketone (Sigma-Aldrich, Germany) 
N,N,N',N'-Tetramethylethylenediamine (TEMED) (Roth, Germany) 
Native Gel Starter Kit (Serva electrophoresis, Germany) 
Nitrate silver (Sigma-Aldrich, Germany) 
Non-fat dry milk powder (Roth, Germany) 
Paraformaldehyde (Roth, Germany) 
Penicillin/streptomycin (GIBCO-Invitrogen, Germany) 
Pharmalyte 5-9 (Serva electrophoresis, Germany) 
Phenol red–free RPMI 1640 (GIBCO-Invitrogen, Germany) 
Phenylalanyl prolyl arginine chloromethyl ketone (PPACK) (Calbiochem, Germany) 
Phorbol myristate acetate (PMA) (Sigma-Aldrich, Germany) 
Picogreen dsDNA kit (Molecular Probes, Invitrogen, Germany) 
Protease Inhibitor cocktail complete (Roche, Germany) 
Rabbit IgG isotype antibody (Dianova, Germany) 
Rat anti-mouse CD16/CD32; Mouse BD Fc Block (BD Pharmingen, Germany) 
Sodium dodecyl sulfate (SDS) (Roth, Germany) 
Spermine–Nitric oxide complex hydrate (Sigma-Aldrich, Germany) 
Staurosporine (Sigma-Aldrich, Germany) 
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Tris (hydroxymethyl) aminomethane (TRIS) base (Roth, Germany) 
Trisodium citrate dehydrate (Roth, Germany) 
Triton X-100 (Sigma-Aldrich, Germany) 
Trypan blue (Sigma-Aldrich, Germany) 
TrypLE Express (GIBCO-Invitrogen, Germany) 
Trypsin; sequencing grade (Promega, Germany) 
Urea (Sigma Aldrich, Germany) 
Vectashield mounting medium with DAPI (Vector Laboratories, USA) 
Vector M.O.M. Immunodetection Kit (Vector Laboratories, USA) 
VersaDoc system (BioRAD, Germany) 
 
 
3.1.2 Equipment 
 
96-well black flat bottom polystyrene not treated microplate (Corning Life Science, 
Germany) 
96-well white flat bottom polystyrene not treated microplate (Thermo Scientific, Germany) 
CASY Cell Counter System (Schaerfe Systems, Germany) 
Cell culture incubator  (Heraeus, Germany) 
Disposable pipettes (2 ml, 5 ml, 10ml, 25 ml, 50 ml) (Greiner Bio-One, Germany) 
ELx 808 absorbance ultra microplate reader (BIO-TEK Instruments, Germany) 
Eppendorf tubes (0.5 ml, 1.5 ml, 2.0 ml) (Eppendorf, Germany) 
ExQuest spot cutter (Bio-Rad, Germany) 
Facscalibur flowcytometer (BD Biosciences, Germany) 
Falcon tubes (Greiner Bio-One, Germany) 
Fluorescence and light microscope (Leica Microsystems, Germany) 
FLx 800 fluorescence microplate reader (BIO-TEK Instruments, Germany) 
Gel blotting paper (GE Healthcare, Germany) 
Hyperfilm ECL (GE healthcare, Germany) 
Labofuge 400 R (Heraeus, Germany) 
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Lab-Tek chamber slides (Thermo Scientific, Germany) 
Micro centrifuge 22 R (Hettich, Germany) 
Petri dishes (Greiner Bio-One, Germany) 
Pipetboy (Integra bioscience, Germany) 
Pipettes tips: 2; 20; 200; 1000 μl (Eppendorf, Germany) 
Protean II XI cell (Bio-Rad, Germany) 
Spectrophotometer; Specord 10 (Zeiss, Germany) 
Tissue culture dishes (Greiner Bio-One, Germany) 
Ultraflex TOF/TOF mass spectrometer (Bruker Daltonics, Germany) 
VersaDoc system (Bio-Rad, Germany) 
Vortex machine (VWR, Germany) 
Water bath (Memmert, Germany) 
 
 
3.2 Methods 
3.2.1 Animal treatment 
C57BL/6J mice were purchased from Charles River (Sulzfeld, Germany). To generate acute 
lung injury, mice (n=3 per group) were treated with a 50 µl PBS suspension of 10 µg LPS 
administrated intratracheally via a cannula. Control mice were treated with 50 µl PBS. 
Following LPS treatment, mice were sacrificed after 3, 6, 12, 24 and 48 h and BAL fluid was 
collected for neutrophil counting or isolation. The lungs were perfused and shock frozen for 
24 h at room temperature. All experiments were performed in accordance with the guidelines 
of the Ethics Committee of the University of Giessen, School of Medicine, and approved by 
local and national authorities. 
3.2.2 Isolation of neutrophils from BAL and immunofluorescence of isolated neutrophils 
Mice treated with LPS for 24 h were sacrificed, BAL was collected and mouse neutrophils 
were isolated by anti-Ly-6G MicroBead kit according to the manufacturer’s protocol. Isolated 
neutrophils were seeded on coverslips and treated with 25 nM PMA for 1.5 h at 37ºC. Cells 
were fixed with 2% PFA, blocked (3% BSA in PBS) and incubated with primary antibodies 
anti-DNA/histone H1 and anti-CD46, which were detected with secondary antibodies 
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coupled to Alexa Fluor 555 donkey anti-mouse IgG and Alexa Fluor 488 donkey anti-rabbit, 
respectively. Controls were done with isotype-matched controls or by omitting the primary 
antibodies. Vectashield mounting medium with DAPI was used for nucleus detection. The 
images were taken by fluorescence microscopy using Metamorph imaging software version 
series 7.0. 
3.2.3 BAL collection, MNase digestion and neutrophil elastase activity  
C57BL/6 mice were treated intratracheally with LPS as mentioned above and BAL was 
collected after 3, 6, 12, 24 and 48 h following treatment. Control mice were treated with PBS. 
BAL was centrifuged 1000 g for 5 min. The supernatants (each 500 µl) were collected and 
each pellet was resuspended with 500 µl PBS. The lysates were digested with 500 mU/ml 
micrococcal nuclease (MNase) from Staphylococcus aureus (Fuchs et al., 2007). Both 
digested lysate (to detect NET-derived elastase) and supernatant (to detect free elastase) were 
incubated with peptide substrate N-(methoxysuccinyl)-Ala-Ala-Pro-Val 4-nitroanilide for 15 
min and the optical density was measured at 405 nm (ELx 808 absorbance ultra microplate 
reader). BAL collection was performed with the help of Dagmar Hensel (Department of 
Internal Medicine II, Giessen). 
3.2.4 Isolation of neutrophils from mice bone marrow 
Mice were sacrificed, the skin was separated from the legs and the muscles were removed 
from the bones. The thigh and the shank were cut and put in a Petri dish containing wash 
buffer (HBSS + 25 mM Hepes + 10% FCS). The ends of the bones were cut and bones were 
washed with a (insulin) syringe filled with wash buffer. The bone-marrow suspension was 
filtered with cell-filter (70 µm pore-size) and centrifuged at 300 g for 10 min. The 
supernatant was removed and the pellet was resuspended in 1 ml HBSS + Hepes. The 
suspension was put carefully on a gradient containing 4 ml Histopaque-1119 under 4 ml 
Histopaque-1077 (in a 15 ml tube). After centrifugation at 700 g for 30 min without break, 
the upper phase was removed and the second phase (around 4 ml) was put in a 50 ml tube 
with 20 ml wash buffer. The suspension was centrifuged again 300 g for 10 min. Following 
centrifugation, 12.5 ml supernatant was removed and 12.5 ml wash buffer was added to the 
tube, resuspended and centrifuged again at 300 g for 10 min. Then, the whole wash buffer 
was removed; the cells were washed again with 20 ml wash buffer and centrifuged at 300 g 
for 10 min. Thereafter, the wash buffer was removed and the cells were resuspended in RPMI 
1640 medium without phenol red. The cells were counted and viability was assessed by 
trypan blue dye. Purity was checked by flow cytometry using FITC rat anti-mouse Ly-6G and 
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Ly-6C. FITC Rat IgG2b and purified rat anti-mouse CD16/CD32 were used as isotype 
control and blocking antibody, respectively. The protocol for mouse neutrophil isolation was 
kindly provided by Dr. Friedemann Kiefer’s group (Max-Planck-Institute for Molecular 
Biomedicine, Muenster). 
3.2.5 Isolation of neutrophils from human blood 
Human neutrophils were isolated from healthy donors using density gradient separation 
according to the protocol (Costa et al., 2006). Briefly, a double gradient was formed by 
layering an equal volume of histopaque-1077 over histopaque-1119. Venous blood was 
collected in EDTA tubes and carefully layered onto the upper histopaque-1077. The blood 
was centrifuged at 700 g for 30 min. The granulocytes are found at the 1077/1119 interphase. 
The cells were collected, washed with PBS and erythrocytes were lysed by incubation in cold 
ddH2O for 1 min. Purity was assessed 96% by labeling the cells with neutrophil-specific 
marker CD66b, and viability was measured 99% by trypan blue dye exclusion. 
3.2.6 Treatment of neutrophils with extracellular adherence protein 
Human neutrophils were incubated with different concentrations of extracellular adherence 
protein (Eap) from Staphylococcus aureus strain Newman (crude protein gift from Prof. 
Mathias Herrmann, Saarland University; purified by Uwe Schubert, Biochemisrty  
Department, Medical School, Giessen) in the absence or presence of PMA, and cell 
morphology and NET formation were evalulated. To quantify NET formation in the presence 
of Eap, the ratio of anti-DNA/histone H1 antibody area per total cell numbers was evaluated 
by Metamorph imaging software. Minimum 1200 cells were counted for each condition. 
Besides PMA, neutrophils were also incubated with other NET-inducing stimuli such as LPS 
or NO donor (Spermine–Nitric oxide complex hydrate, gift from Dr. Mike Althaus, Institute 
of Animal Physiology, Giessen) and NET formation was evalulated in the absence or 
presence of Eap. 
3.2.7 Mouse lung immunofluorescence 
Frozen 5 μm lung tissue sections from mice treated intratracheally with 10 µg LPS or PBS 
were equilibrated to room temperature and fixed in acetone for 10 min. Vector M.O.M. 
Immunodetection kit was used with some modifications in the protocol. Briefly, after fixation 
the sections were washed with PBS and blocked with working solution of M.O.M mouse Ig 
blocking reagent for 1 h. The sections were incubated with primary antibodies anti-CD46 or 
anti-neutrophil elastase (M-18) followed by a secondary antibody coupled to Alexa Fluor 488 
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and anti-DNA/histone 1 coupled with Alexa Fluor 546. Negative control slides were obtained 
by either omitting the primary antibodies or by using the isotype-matched controls. DAPI was 
used for nucleus detection. 
3.2.8 Epithelial and endothelial cell treatment with histones 
A549-human lung adenocarcinoma cell lines were obtained from American Type Culture 
Collection (ATCC). Human umbilical vein endothelial cells (HUVEC) were isolated as 
described (Jaffe et al., 1973). Human A549 cells and HUVEC were treated with 10 to 200 
µg/ml of histones type IIA from calf. The supernatants were collected for cytotoxicity assay 
or analysis of the release of lactate dehydrogenase (LDH) enzyme from the cells. Cell 
morphology was analyzed under the light microscope (Leica Microsystems) and the cell 
numbers were counted by CASY Cell Counter System. 
3.2.9 NET production, isolation and NET-DNA quantification 
Human neutrophils were resuspended in phenol red–free RPMI 1640, and 1.8 x 106 cells per 
well were seeded in 6-well plate. One well left untreated and the others were stimulated with 
50 nM PMA for 4 h. Thereafter, the media from all wells were carefully removed. To remove 
the remaining components which are not bound tightly to the NET, 1 ml RPMI was added per 
well and carefully removed again. To collect NET, 2 ml RPMI was added per well and NET 
(the smear on the wells) was collected in 15 ml tubes by vigorous agitation. After 
centrifugation at 20 g for 5 min, NET were collected in the supernatant and subjected to 
different treatments, including partial digestion by 500 U/ml MNase for 10 min at 37ºC or 
complete digestion by 10 U/ml DNase I (Fermentas, Germany) for 20 min at 37ºC or kept 
undigested. An aliquot from each tube was used for quantification of DNA in NET by 
picogreen dsDNA kit according to the manufacturer's instructions. The protocol for NET 
isolation was kindly provided by Dr. Volker Brinkmann (Max-Planck-Institute for Infection 
Biology, Berlin). 
3.2.10 NET Protein quantifications 
Protein quantification in NET was performed by micro-BCA protein assay reagent kit. For 
two-dimensional gel electrophoresis (2-D gel electrophoresis) analysis, 2-D Quant kit was 
used for protein quantification. Both methods resulted in the same values of protein 
concentration. 
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3.2.11 Treatment of lung epithelial cells with NET 
A549 cells were seeded in 24-well plate to become confluent, washed once with PBS, and 
NET in different concentrations was added to each well, whereby 800 μl or 2400 μl from 
isolated NET equal to 3.4 (NET) and 10.1 (3 x NET) µg/ml DNA-NET, respectively, were 
added to different wells. Some wells were treated with 3.3 μg/ml staurosporine as a cell death 
inducer and some left untreated as controls. The total volume of each well was kept constant 
by adding RPMI medium. Cells were analyzed after 4 h or 16 h with different measurements 
(such as qualification of LDH and multicaspase activity). 
3.2.12 Cytotoxcicity assay 
A549 cells were treated with 1% Triton X-100 (maximum LDH release or “high control”), 
with NET or kept untreated (spontaneous LDH release or “low control”). LDH release in the 
supernatant was assessed by cytotoxicity detection kit according to the manufacturer's 
instructions. Cytotoxicity percentage was calculated as follows:  
                                 100
controllowcontrolhigh
controllowexp.value(%)tyCytotoxici 
                             
“Exp.value” refers to the average absorbance of the experimental cells (cells treated with 
histones or NET). 
3.2.13 Detection of activated caspases in living cells 
Green multi-caspase staining kit was used to detect activated caspases in living cells 
according to the manufacturer’s protocol. In brief, A549 cells were left untreated or treated 
with NET, staurosporine or caspase inhibitor Z-VAD-FMK as an additional negative control. 
After incubation, the supernatants were collected in different tubes, and cells were trypsinzed 
and added to the collected supernatants. The tubes were centrifuged at 900 g for 5 min and 
the supernatants discarded. Then 300 μl from the induced and control cells were aliquoted 
into reaction tubes. FITC-VAD-FMK (1 μl) was added into each tube and incubated for 30 
min at 37°C with 5% CO2. The cells were centrifuged at 900 g for 5 min and the supernatant 
was removed. The cells were resuspended in 0.5 ml of wash buffer and cell suspensions (100 
μl from each sample) were transferred to wells of a black microtiter 96-well plate. The 
fluorescence intensity was measured at excitation and emission wavelengths of 485 nm and 
535 nm, respectively (FLx 800 fluorescence microplate reader). 
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3.2.14 Apoptotic/necrotic detection by fluorescence microscopy 
NET- and staurosporine-treated or untreated A549 cells were stained with FITC-annexin V, 
ethidium homodimer III and Hoechst 33342 according to the manufacturer's instructions. In 
brief, after culturing the epithelial cells on coverslip, cells were treated with NET or 
staurosporine for 16 h, then washed with binding buffer and incubated with the staining 
solution (5 μl of FITC-annexin V, 5 μl of ethidium homodimer III and 5 μl of Hoechst 33342 
into 100 μl of binding buffer) for 15 min at 37°C. After washing the slides with binding 
buffer, cell staining was evaluated with the fluorescence microscope (Leica Microsystems) 
using separate filters for FITC, rhodamine and DAPI.  
3.2.15 Histones and NET treatment with activated protein C (APC) 
Histone type IIA (100 or 200 µg/ml) from calf thymus was incubated with 6 µg/ml (100 nM) 
APC for 1 h at 37°C (Xu et al., 2009). In addition, NET (approximately 10 µg/ml protein 
content), digested or non-digested, was incubated with 100 nM APC for different time 
intervals. Moreover, NET was incubated with APC at different mass ratios of APC: NET 
(1:5, 1:2, and 1:1) for 1 h at 37°C. APC alone or APC plus 6 µM APC inhibitor (PPACK) 
were used as controls. LDH release by A549 cells was measured after treatment with 
histones, APC, NET, APC plus histones and APC plus NET. 
3.2.16 Western Blot analysis    
Confluent HUVEC or A549 cells in 24-well plate were stimulated with different 
concentrations of NET for 4 h or left untreated.  The cells were harvested and lysed with 70 
μl per well ice-cold modified RIPA buffer (150 mM NaCl, 1mM EDTA, 1% sodium 
deoxycholate, 50 mM Tris, pH 7.4, 0.1% SDS) that was supplemented with protease inhibitor 
cocktail tablets on ice. Cellular lysates were centrifuged at 17000 g for 15 min at 4°C to 
remove insoluble material. For Western blotting, 20 µl from lysates were resolved on a 15% 
SDS-PAGE gel and blotted onto a polyvinylidene fluoride membrane. A polyclonal rabbit 
anti-caspase-3 antibody was used to detect the endogenous level of full length caspase-3 (35 
kDa) and the large fragment of caspase-3 resulting from cleavage (17 kDa). The membrane 
was incubated for 5 min with ECL detection reagent to detect caspase antibody. Then, the 
membrane was stripped with stripping buffer (0.1 M glycine, pH 3), washed, blocked and 
reprobed with an anti–β-actin antibody for visualizing loading control. 
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3.2.17 NET fractionation and native-gel electrophoresis 
DNase digested NET (4 ml, containing 10 µg/ml protein content) were centrifuged at 2500 g, 
and the supernatant were subjected to 30 and 50 kDa Amicon ultra-4 centrifugal filter unit in 
order to fractionate NET proteins based on the size. The final volumes of both concentrate 
(on top of the filter) and eluent were reached to 4 ml with RPMI medium and added to A549 
cells or subjected to SDS–PAGE or blue native gel (Serva). For SDS-PAGE, 3.5 µg protein 
per well were loaded and stained with Flamingo. For native gel electrophoresis, 6.8 µg 
protein were loaded, run for 2 h at 200 V (constant) and stained with silver nitrate. Bands 
were cut and proteins were identified with matrix-assisted laser-desorption ionization time-
of-flight mass spectrometry (MALDI-TOF-MS). 
3.2.18 Two-dimensional gel electrophoresis 
2-D gel electrophoresis was performed for untreated neutrophils, PMA-treated neutrophils, 
NET samples or NET-treated epithelial cells. For proteomic analysis of epithelial cells after 
NET treatment, confluent A549 cells in 24-well plates were treated with 800 μl non-digested 
or DNase digested NET (10 µg/ml protein) for 1, 3, 6 or 8 h, and untreated cells were used as 
controls. After incubation, the supernatants of the wells were discarded, wells were washed 
once with PBS, and the cells were collected and treated with lysis buffer for 2-D gel 
electrophoresis. Protein extraction was performed by ultrasonication in 100 μl 6 M urea, 2 M 
thiourea, 4% CHAPS, 1% Dithiothreitol (DTT) and 2% Pharmalyte 3-10, and protein 
quantification was performed with 2-D Quant kit. IPG-strips (pH 3-10 NL for epithelial 
proteins, pH 3-10 and pH 7-11 NL for NET-proteins) were rehydrated at 20°C with the 
protein extract. On each strip, 400 µg protein were applied and isoelectric focusing was 
performed with 32.05 kVh. After focusing, the IPG-strips were equilibrated for 10 min in 2 
ml equilibration stock solution (ESS; 6 M urea, 0.1 mM EDTA, 0.01 % bromphenol blue, 50 
mM Tris-HCl pH 6.8, 30 % glycerol) for 15 min in 2 ml ESS I (10 ml ESS containing 200 
mg SDS, 100 mg DTT) followed by 15 min in ESS II (10 ml ESS containing 200 mg SDS, 
480 mg iodacetamide). Protein separation in the second dimension was performed by 
electrophoresis on 12.5% SDS polyacrylamide gels according to Laemmli (Laemmli, 1970). 
Electrophoresis was carried out in a Hoefer 600 system with the following program: 15 min 
at 15 mA/gel and 5 h at 110 mA at 25°C. Gels were stained with coomassie brilliant blue R-
250 or silver nitrate and scanned with a GS-800 densitometer (BioRAD). 
Material and methods 
30                           
3.2.19 Differential in gel electrophoresis (DIGE) derivatization  
For DIGE derivatization using the minimal labeling kit, 100 µg of NET-proteins before or 
after treatment with APC were derivatized with Cy3 and Cy5, respectively, according to the 
instructions of the manufacturer (GE Healthcare). From both samples, 50 µg proteins were 
mixed and labeled with Cy2 as an internal standard. All three samples were mixed and 
subjected to 2-D gel electrophoresis, and proteins were separated according to their pI by 
isoelectric focusing on IPG strips (13 cm, pI 7-11 NL) with 32.05 kVh. For the second 
dimension, 12.5% polyacrylamide gels were used. Gels were scanned with a VersaDoc 
system from BioRAD, and gel images were analyzed with PdQuest software. 
3.2.20 Tryptic in-gel digestion of proteins  
Spots of interest were excised with the ExQuest spot cutter (BioRAD) and proteins were 
digested with trypsin on a liquid handling roboter system (MicroStarlet, HamiltonRobotics). 
3.2.21 MALDI-TOF-MS analysis 
MALDI-TOF-MS was performed on an Ultraflex TOF/TOF mass spectrometer equipped 
with a nitrogen laser and a LIFT-MS/MS facility. The instrument was operated in the 
positive-ion reflectron mode using 2.5-dihydroxybenzoic acid and methylendiphosphonic 
acid as matrix. Sum spectra consisting of 200–400 single spectra were acquired. For data 
processing and instrument control the Compass 1.1 software package consisting of 
FlexControl 2.4, FlexAnalysis 3.0 and BioTools 3.0 was used. All 2-D gel electrophoreses, 
gel digestions and mass spectrometry were performed by Dr. Guenther Lochnit 
(Biochemistry Institute, Medical School, Giessen). 
3.2.22 Database search 
Proteins were identified by MASCOT peptide mass fingerprint search 
(http://www.matrixscience.com) using the human IPI database. For the search a mass 
tolerance of 75 ppm was allowed and carbamidomethylation of cysteine as global 
modification and oxidation of methionin as variable modification were used. 
3.2.23 Cystic fibrosis sputum staining 
Sputum from 6 cystic fibrosis patients (inhaled with 5.85% hypertonic sodium chloride to 
collect sputum) was treated with 10% DTT for 20 min at 37°C and seeded on the coverslip. 
Moreover, DTT-treated sputum was centrifuged at the highest speed and the supernatant was 
seeded on the coverslip. The samples were fixed with 2% PFA, blocked (3% BSA in PBS) 
and incubated with primary antibodies anti-DNA/histone H1 and anti-neutrophil elastase 
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which were detected with secondary antibodies coupled to Alexa Fluor 555 donkey anti-
mouse IgG and Alexa Fluor 488 donkey anti-rabbit, respectively. Cystic fibrosis sputum 
collection and the protocol for sputum treatment were kindly provided by Dr. Lutz Naehrlich 
(Pediatric Clinic, UKMG, Medical School, Giessen). 
3.2.24 Macromolecule permeability of epithelial cells  
The permeability of trypan blue-labeled albumin across human lung epithelial cells (A549) 
was studied in a two-compartment system separated by a filter membrane as described 
previously (Null et al., 1999; Pfeil et al., 2009). Cells were grown in DMEM full medium 
until they became confluent, and at the day of experiment they were grown in RPMI phenol 
red-free medium for controls or they were incubated with 2.5 ml (approximately 30 µg/ml 
protein content) of undigested or DNase-digested NET. There was no hydrostatic pressure 
gradient between both compartments. The "luminal" compartment containing the monolayer 
had a volume of 2.5 ml, and the "abluminal" of 6.5 ml. The fluid in the "abluminal" 
compartment was constantly stirred. Trypan blue-labeled albumin (60 μM) was added to the 
luminal compartment. The appearance of the labeled albumin in the abluminal compartment 
was monitored by pumping the liquid through a spectrophotometer (Specord 10). The 
concentration of labeled albumin in the luminal compartment was determined every min of 
incubation.  
The albumin flux [F, expressed as mol/(sec x cm2)] across the monolayer with the surface (S) 
was determined from the increase of albumin concentration (d[A]2) during the time interval 
(dt) in the abluminal compartment (volume V): 
                                                          F = (d[A2] / dt x V) / S. 
The permeability coefficient (P, expressed as cm/sec) of the combined system of monolayer 
and filter support was calculated from F according to Fick’s law of diffusion as follows  
                                                            P = F / ([A]1 - [A]2) 
where [A]1 and [A]2 denote tracer concentrations in the luminal and abluminal compartments, 
respectively. The driving force ([A]1 - [A]2) remained almost unchanged in the course of the 
described experiments, therefore the relative changes in F correspond to similar changes in 
the permeability coefficient. Here, the permeability (F) is shown in percentage in comparison 
to the control cells, while the permeability of the control cells was considered 100%. 
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Permeability experiments and the analysis were performed together with Dr. Muhammad 
Aslam (Physiology Department, Medical School, Giessen). 
3.2.25 Inhibition of NET cytotoxicity 
To test the influence of NET on cytotoxicity, 800 µl NET (approximately 10 µg protein 
content) was pre-incubated with 1:100 of antibodies against H2A, H3, CitH3 (citrulline 2 + 8 
+ 17) or H4, or with 8 µg of antibodies against DNA/histone H1, H2B, mouse IgG isotype or 
rabbit IgG isotype for 1 h at room temperature before incubation of NET with epithelial cells. 
In addition, 800 µl NET was pre-incubated with 37 ng/ml myeloperoxidase inhibitor 
dihydrolipoic acid (gift from Dr. Oliver Soehnlein, Ludwig-Maximilians-University Munich), 
2 µl (0.25 mM) neutrophil elastase inhibitor N-(methoxysuccinyl)-Ala-Ala-Pro-Val-
chloromethyl ketone or 50 µg/ml polysialic acid (PSA) (gift from Dr. Sebastian Galuska, 
Biochemistry Institute, Medical School, Giessen) for 1 h at room temperature before 
incubation of NET with epithelial cells. 
3.2.26 Statistical analysis 
Data were analyzed by GraphPad Prism 5.02 software using one-way analysis of variance 
(ANOVA) with Tukey post-tests for multiple comparisons or by student’s t-test for single 
measurements. Each experiment was performed at least 3 times on independent occasions, 
unless otherwise stated. Differences were considered statistically significant at P<0.05 
(except for proteomics analysis; P<0.02) and data were expressed as mean   SD (n   3).  
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4 Results 
4.1 PMA-stimulated neutrophils show upregulation of proteins in comparison to the 
unstimulated ones. 
Stimulation of neutrophils to form NET was done mainly by PMA. In order to compare 
PMA-stimulated neutrophils with the unstimulated ones, 2-D gel electrophoresis was 
performed for both conditions (Fig. 4.1A and B). From 28 randomly selected spots, almost all 
spots (27 spots) showed upregulation in stimulated cells (Fig. 4.2A and B). 
          
 
 
Figure 4.1: Two-dimensional gel electrophoresis for unstimulated and PMA-stimulated neutrophils. (A) 
and (B) Comparison of 2-D gel electrophoresis (pI 3-10) of unstimulated and PMA-stimulated neutrophils (two 
gels per each group). Stimulated and unstimulated are shown by red and green, respectively. 
B 
A 
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Figure 4.2: Upregulated proteins in PMA-stimulated neutrophils in comparison to the unstimulated ones. 
(A) Selected spots in the stimulated gel were shown. (B) Stimulated spots showed upregulation (red) in 
comparison to the unstimulated matched spots (green). Differences were considered statistically significant at 
P<0.02. 
A 
B 
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4.2 Identification of NET proteins by 2-D gel electrophoresis and MALDI-TOF-MS  
2-D gel electrophoresis was performed for NET-proteins at different pI ranges (3-10 and 7-
11). From 32 randomly chosen spots in NET, we identified 13 different kinds of proteins 
(Table 4.1) from which 9 proteins have already been identified by another group (Urban et 
al., 2009). Four different proteins were identified for the first time (indicated by *). 
Table 4.1 Identified NET proteins by 2-D gel electrophoresis and MALDI-TOF-MS and their functions 
NET-proteins * Newly identified NET-proteins Functions (source: uniprot) 
Annexin A1 
 
* 
Membrane fusion, exocytosis, 
calcium/phospholipid-binding protein 
Lactoferrin 
 
 
Cellular iron ion homeostasis, iron ion 
transport, antimicrobial activity 
Profilin-1 * 
Actin cytoskeleton organization,   
platelet activation 
Alpha-enolase  
Glycolysis, Plasminogen activation, 
Transcription regulation 
Protein S100-A8 and A9  
Calcium-binding protein, chemotaxis, 
antimicrobial activity 
Glyceraldehyde 3-phosphate 
dehydrogenase 
* 
Glycolysis, nitrosylase activities, 
transcription, RNA transport,            
DNA replication, apoptosis 
Actin, cytoplamsmic 1 and 2  
Adherens junction organization, 
cytoskeleton, cell motility 
Leukocyte elastase inhibitor 
(Serpin B1) 
* Regulation of proteolysis 
Plastin-2  Actin-binding protein, T cell activation 
Myeloperoxidase  Microbicidal activity 
Proteinase 3  
Serine protease which degrades 
extracellular matrix 
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4.3 NET formation in lung tissue and BAL fluid of LPS-induced lung injury model  
Under physiological conditions and in the absence of infectious or inflammatory stimuli, 
there is less than one million PMN in the lung tissue and no PMN in the BAL fluid 
(Reutershan et al., 2005). To recruit PMN to the lung in considerable number, LPS was 
instilled intratracheally into the mice to induce LPS-mediated acute lung injury. NET 
formation was observed in mouse lung tissue after LPS treatment as compared to PBS 
controls. NET formation was demonstrated by the appearance of extracellular chromatin and 
disintegration of cell membranes (Fig. 4.3A) as well as co-localization of extracellular 
chromatin with neutrophil elastase (Fig. 4.3B). In general, decondensated chromatin in NET 
showed weak signal for DAPI staining, while it was detected strongly by DNA/histone 
antibody. Presence of short fragments of DNA–protein complexes in the airways (Douda et 
al., 2011) may explain the non-frequent NET detected structures in the tissue. 
Moreover, after 3 to 48 h of stimulation with LPS, BAL fluid was collected and the numbers 
of PMN were counted. Application of LPS provoked maximal recruitment of neutrophils 
after 24 h (Fig. 4.4A). Treatment of NET with DNase such as MNase leads to dissociation of 
NET-DNA from NET-proteins. Treatment of BAL pellet with MNase (NET-related elastase, 
filled bars) showed significant increase in neutrophil elastase activity in comparison to the 
activity in the BAL supernatant (free elastase, open bars) after 12 h LPS stimulation which 
indicates NET formation (Fig. 4.4B). Together, these data show NET formation in the BAL 
and lung tissue in LPS-induced lung injury model. To characterize NET formation in BAL, 
mouse neutrophils in BAL after 24 h LPS stimulation were stained for chromatin and cell 
membrane marker CD46. Since non-LPS stimulated neutrophils, as negative controls, could 
not be isolated from BAL, stimulation with PMA was used as positive control. Therefore, 
some of these neutrophils were further stimulated with PMA, a potent inducer of NET 
formation, for 1.5 h in vitro. While LPS, which induces neutrophil recruitment, provoked 
NET formation to a certain extent, it was more pronounced in cells stimulated with PMA 
(Fig. 4.4C).  
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Figure 4.3: NET formation in mice lung tissue after LPS treatment. (A) Immunofluorescence staining of 
lung sections from mice after 24 h intratracheal LPS administration was performed, as compared to the control 
section, for DNA/histone (red), CD46 (green) as a cell membrane marker and DAPI (blue). The insets (1, 2 and 
3) showed NET formation in LPS-treated lungs in higher magnification views. Note that in NET regions, DAPI 
had been blurred as opposed to sharp signal detected for DNA/histones which identified the decondensated 
chromatin. (B) Immunofluorescence staining of sections from control or LPS-treated mice were performed for 
DNA/histone (red), neutrophil elastase (green) and DAPI (blue). The higher magnification views of the insets (4 
and 5) showed co-localization of neutrophil elastase (green) and DNA/histone (red) in NET structures. 
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Figure 4.4: NET formation in mice BAL fluid after LPS treatment. (A) Following intratracheal LPS 
administration, PMN in the BAL fluid of mice were counted at different time intervals. (B) At the same time 
intervals, neutrophil elastase activity was measured in the supernatant of BAL fluid (free elastase, open bars) as 
well as in the MNase-digested pellet of BAL fluid (NET-related elastase, filled bars). Differences were 
considered statistically significant at *** P<0.001. (C) PMN were isolated from BAL fluid of mice stimulated 
intratracheally with LPS for 24 h, and immunofluorescence staining of isolated cells was performed for 
DNA/histone (red), CD46 (green) and DAPI (blue) (upper row). Isolated PMN were further stimulated with 
PMA for 1.5 h (lower row); arrows indicate NET formation. 
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4.4 NET qualification and quantification 
Different methods were used for NET quantification in mice and human including 
immunocytochemistry, picogreen dye, sytox orange and FACS. Immunocytochemistry with 
DAPI and DNA/histone was the best method for qualification and quantification since the 
structure of the nucleus, which is very important for NET detection, can also be evaluated; 
decondensation of the nucleus indicates NET formation (Fig. 4.5A). Picogreen dye was also a 
very sensitive method to quantify NET-DNA concentration. Sytox orange was a fast and 
quite easy method for quantification; however, the sensitivity was not as high as other 
methods (Fig. 4.5B). For the first time FACS analysis for NET quantification in mice 
neutrophils was used by measuring the signal for labeled-DNA/histone antibody and the 
amount of degranulation: The more NET formation, the more signal for labled-DNA/histone 
and the more degranulation (Fig. 4.5C). For practical reasons, the following experiments 
were performed with human neutrophils which exhibited NET formation in a similar way. 
4.5 Eap inhibits NET formation in a dose-dependent manner  
The interaction between neutrophils and bacteria including Staphylococcus aureus in respect 
to NET formation has been described (Pilsczek et al., 2010). However, there is no report 
concerning the role of extracellular adherence protein of S. aureus, Eap, in NET formation. 
Eap is a secreted protein from S. aureus which has a very wide range of binding interactions 
to host extracellular matrix components (Harraghy et al., 2003; Chavakis et al., 2005). Eap 
has an anti-inflammatory function by disrupting integrin-dependent neutrophil–endothelial 
interactions, and S. aureus may use this property to escape the host immune system 
(Chavakis et al., 2002). Interestingly, incubation of human neutrophils by Eap from strain 
Newman did not induce NET formation but promoted neutrophil aggregation (Fig. 4.6A). 
DNA/histone antibody has more affinity for decondensated chromatin such as chromatin in 
NET structure. Surprisingly, Eap inhibited PMA-induced NET formation in a dose-dependent 
manner, as it was shown by the reduction in DNA/histone antibody areas (Fig. 4.6B and C). 
Eap had the same effect when neutrophils were treated with different NET-inducing stimuli 
such as LPS (Fig. 4.6D) or NO donor (Fig. 4.6E). Co-incubation of Eap with NO donor also 
led to aggregation of neutrophils. Pre-incubation of cells with Eap for 30 min had similar 
effects when cells were pre-incubated with PMA, LPS or NO donor. 
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Figure 4.5: Different NET quantification methods. (A) Nucleus structural changes in PMN after 1 h or 3 h 
stimulation with 25 nM PMA were shown by staining the cells with DAPI. Note that decondensation of the 
nucleus indicates NET formation. (B) NET Quantification was performed for different PMN numbers and PMA 
concentrations using sytox orange. (C) and (D) FACS analysis was used to quantify NET formation. Decrease in 
side scatter (SSC) intensity and increase in signal for the labeled-DNA/histone after 1 h to 3 h stimulation with 
25 nM PMA showed NET formation. 
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Figure 4.6: Eap induces neutrophil aggregation and inhibits NET formation. (A) Neutrophils were 
incubated with Eap or PMA and nucleus structures (DAPI: gray) were shown. Note that Eap alone did not 
induce NET formation but triggered neutrophil aggregation (arrows). (B) and (C) Eap inhibited PMA-induced 
NET formation in a dose-dependent manner; DAPI (blue) and DNA/histone (red). (D) Eap (10 µg/ml) inhibited 
LPS (10 µg/ml)-induced NET formation. (E) Eap (10 µg/ml) inhibited NO (100 nM)-induced NET formation.  
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4.6 NET induce cell death in epithelial cells in a dose-dependent manner 
A549 cells were incubated with MNase-digested NET or staurosporine for 4 h or 16 h. While 
untreated cells grew normally and became confluent, cells treated with NET or staurosporine 
did not reach confluency (Fig. 4.7A). Multicaspase activity in A549 cells increased 
significantly after exposure to staurosporine or NET in a dose-dependent manner (Fig. 4.7B). 
Moreover, NET exposure increased the fractions of annexin V and ethidium homodimer (a 
membrane-impermeable fluorescent dye which binds to DNA in dead cells) positive cells 
(Fig. 4.7C). NET also increased caspase-3 cleavage in both epithelial and endothelial cells 
(Fig. 4.7D). Together, these data indicate that endothelial and lung epithelial cell death is 
induced by NET in a dose-dependent manner. 
            
                                    
Figure 4.7: NET induce cell death in epithelial cells in a dose-dependent manner. (A) The morphology of 
A549 cells was evaluated after 4 or 16 h treatment with medium (control), NET or staurosporine; magnification: 
20x. (B) Multicaspase activity of A549 cells was measured after 16 h treatment with NET, staurosporine (Stau) 
or staurosporine together with caspase inhibitor (CI). DNA-NET concentration in NET and 3 x NET were 3.4 
and 10.1 µg/ml, respectively. Differences were considered statistically significant at * P<0.05, ** P<0.01, and 
*** P<0.001. 
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Figure 4.7: NET induce cell death in epithelial cells in a dose-dependent manner. (C) Immunofluorescence 
staining of A549 cells was performed after 16 h treatment with NET or staurosporine for Hoechst filter (gray), 
Hoechst 33342 (blue), annexin V (green) and ethidium homodimer III (red). (D) Immunoblot for caspase-3 
cleavage of A549 and HUVEC cells was carried out after 4 h treatment with NET or staurosporine. a: untreated 
cells, b: cells treated with NET without digestion, c: cells treated with NET after MNase digestion, d: cells 
treated with 3 times higher amount of NET from c, e: cells treated with staurosporine. 
 
 
4.7 NET induce cytotoxicity in lung epithelial and endothelial cells independent of NET 
digestion 
In order to investigate in detail the role of DNA digestion in NET cytotoxicity, three forms of 
NET were used: undigested, completely digested by DNase or partially digested by MNase. 
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Cytotoxicity in A549 cells after incubation with NET was determined by LDH release, where 
cytotoxicity from untreated cells and cells treated with Triton X-100 were considered 0% and 
100%, respectively. Cells treated with NET showed substantially increased cytotoxicity in 
comparison to untreated cells. Moreover, DNase or MNase treatment of NET did not change 
their cytotoxic activity. Incubation of cells with DNase, MNase or DNA alone did not 
provoke any appreciable cytotoxicity. These data indicate that NET induce cytotoxicity in 
epithelial cells independent of the type of DNA digestion (Fig. 4.8 and Fig. 4.7D).  
                                               
Figure 4.8: NET induce cytotoxicity in epithelial cells independent of digestion. LDH release from A549 
cells was measured after 16 h treatment with undigested NET (no dig), completely or partially digested forms of 
NET by DNase and MNase, respectively. The same concentration of DNA alone as DNA-NET (3.4 µg/ml) as 
well as DNase or MNase alone were used as controls. Differences were considered statistically significant at 
*** P<0.001. 
 
 
4.8 Proteomic analysis in NET-treated epithelial cells 
To compare the proteomic profile of epithelial cells before and after NET treatment, 
epithelial cells were incubated from 1 to 8 h with NET or kept untreated. Subsequent 2-D gel 
electrophoresis showed upregulation of different spots in NET-treated epithelial cells in 
comparison to the untreated ones. Identification of proteins by MALDI-TOF-MS revealed a 
wide range of proteins with different functions and cellular localizations (Table 4.2) and 
interestingly, several of these proteins have been reported to play a role in cell death 
(www.uniprot.org). 
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     Table 4.2: Upregulated proteins in epithelial cells after treatment with NET 
Identified proteins (*role in cell death; source: uniprot) Cellular component  
Elongation factor 1-beta  Cytosol  
Heterogeneous nuclear ribonucleoprotein C-like 1  Nucleus  
Isoform C2 of Heterogeneous nuclear ribonucleoproteins C1/C2  
Nucleus 
Spliceosome  
Isoform 2 of Heterogeneous nuclear ribonucleoprotein A1  
Cytoplasm                                       
Nucleus 
Spliceosome  
Heterogeneous nuclear ribonucleoprotein K 
Cytoplasm 
Nucleus 
Spliceosome 
Proliferating cell nuclear antigen  Nucleus  
Isoform 2 and 1 of Tropomyosin alpha-3 and 4 chain  
Cytoplasm                  
Cytoskeleton  
Aldo-keto reductase family 1 member C3  Cytoplasm  
Annexin A1 
Cell membrane 
Cell projection 
Cilium 
Cytoplasm 
Membrane 
Nucleus  
Annexin A2 
Basement membrane 
Extracellular matrix 
Secreted 
Glyceraldehyde-3-phosphate dehydrogenase* 
Cytoplasm 
Membrane 
Nucleus  
Protein disulfide-isomerase 
Cell membrane 
Endoplasmic reticulum lumen 
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Prohibitin* 
Membrane 
Mitochondrion 
Mitochondrion inner membrane 
Ubiquitin carboxyl-terminal hydrolase isozyme L1 Cytoplasm 
F-actin-capping protein subunit alpha-1 
Cytoplasm 
Cytoskeleton 
Aldo-keto reductase family 1 member B10  Cytoplasm 
Transaldolase Cytoplasm 
Glutathione S-transferase omega-1 Cytoplasm 
Protein DJ-1 (Oncogene DJ1, Parkinson disease protein 7) * 
Cytoplasm                          
Nucleus                   
Mitochondrion                   
Retinal dehydrogenase 1 Cytoplasm 
Isoform 1 of Triosephosphate isomerase  Cytosol 
Nitrilase homolog 2 Cytoplasm 
Poly (rC)-binding protein 1 
Cytoplasm 
Nucleus 
Stress-induced-phosphoprotein 1 
Cytoplasm 
Nucleus 
Peptidyl-prolyl cis-trans isomerase A Cytoplasm 
Superoxide dismutase [Mn], mitochondrial* Mitochondrion 
Vitamin K epoxide reductase complex subunit 1-like protein 1 Membrane 
Isoform 1 of Mitochondrial import receptor subunit TOM40 
homolog 
Membrane 
Mitochondrion 
Mitochondrion outer membrane 
Phosphoglycerate kinase 1 Cytoplasm 
 Isoform 1 of Phosphoserine aminotransferase  Cytoplasm 
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Profilin-1 
Cytoplasm 
Cytoskeleton 
60 kDa Heat shock protein, mitochondrial* Mitochondrion 
Heat shock protein beta-1* 
Cytoplasm                          
Nucleus                      
Cytoskeleton 
Proteasome subunit beta type-2* 
Cytoplasm 
Nucleus 
Proteasome 
Proteasome subunit beta type-3 * 
Cytoplasm 
Nucleus 
Proteasome 
Proteasome subunit beta type-4* 
Cytoplasm 
Nucleus 
Proteasome 
Isoform 1 of Proteasome activator complex subunit 3 * 
Cytoplasm 
Nucleus 
Proteasome 
Proteasome 26S non-ATPase subunit 13 isoform 2 * Proteasome 
 
4.9 NET fractionation and native gel electrophoresis 
In order to investigate which proteins in NET are cytotoxic, NET proteins were fractionated 
based on the size, and NET fractions are treated with epithelial cells. In all cases, only the 
high molecular weight fractions (> 50 kDa when NET proteins are fractionated by 50 kDa 
filter) had cytotoxic properties (Fig. 4.9A). In fact, insufficient amounts of proteins from the 
smaller fractions (< 50 kDa) were obtained. Moreover, boiled NET did not show cytotoxicity 
activity, which is an indication that proteins in NET are responsible for the cytotoxicity. 
However, SDS-gel electrophoresis of the fractions > 50 kDa showed bands lower than this 
size which maybe the indication of protein complexes in NET (Fig. 4.9B and Table 4.3). 
Similar results had been also seen when NET fractionated by 30 kDa filter. Therefore, native-
gel electrophoresis, which is a non-denaturing condition, was performed for NET proteins to 
Results 
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investigate possible protein complexes in NET. From randomly selected seven bands, we 
could identify protein complex only in one band (band 6, Fig. 4.10).      
        
                                                                                                                                                                      
Table 4.3: Identified NET proteins; fraction > 50 kDa 
Identified proteins Band number 
Transketolase 1 
Glucose-6-phosphate isomerase 2 
Alpha-enolase 3 
Actin, cytoplamsmic 1 4 
Glyceraldehyde 3-phosphate dehydrogenase 5 
Annexin A1 7 
Actin-related protein 2/3 complex subunit 2 7 
Actin, cytoplasmic 1 7 
highly similar to Actin, cytoplasmic 1 8 
Protein kinase C inhibitor protein 1 8 
Protein S100-A9 10 
Profilin-1 10 
Protein S100-A8 11 
                                                                                                                                                                                 
Figure 4.9: Presence of the protein complexes in NET. (A) Total NET proteins were fractionated by 50 kDa 
filter, and NET or NET fractions were treated with epithelial cells for 16 h to check the cytotoxicty. Only total 
NET proteins and NET fractions > 50 kDa showed cytotoxic affect on epithelial cells. Total boiled NET did not 
induce cytotoxicity, indicating proteins in NET induce cytotoxicity. (B) SDS-gel electrophoresis (15%) was 
carried out for NET fractions > 50 kDa; note that bands < 50 kDa were appeared. Table 4.3 shows the identified 
NET proteins (fraction > 50 kDa) from Fig. 4.9B by MALDI-TOF-MS. Bands 6 and 9: unidentified proteins. 
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Figure 4.10: Native-gel electrophoresis for NET proteins. Blue native-gel electrophoresis (4-16%) was 
performed for NET proteins. Subsequent MALDI-TOF-MS for the specified bands showed protein complex 
only in band 6. Two lanes are NET proteins. Bands 1, 2 and 3: unidentified proteins.    
 
 
4.10 Histones induce epithelial and endothelial cell death 
To elucidate the relevance of histones (as major protein components of NET structure) for 
NET-mediated cytotoxicity, the influence of pure histones on both epithelial and endothelial 
cell death was investigated. Incubation of epithelial and endothelial cells for 16 h with high 
concentration of purified histones (histone type-IIA, which include all types of histones) 
induced cell death (Fig. 4.11A). Histones triggered cell death in epithelial cell in a dose-
dependent manner (Fig. 4.11B and C). Likewise, histones induced cytotoxicity in endothelial 
cells in a dose-dependent manner and similar to epithelial cells, NET provoked cytotoxicity 
in endothelial cells whether DNA is digested in NET or not (Fig. 4.11D).   
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Figure 4.11: Histones induce epithelial and endothelial cell death. (A) HUVEC and A549 cells were treated 
with 200 µg/ml calf histones for 16 h or left untreated (control), and cell morphology was evaluated; 
magnification: 20x. (B) A549 cells were treated with different concentrations of calf histones for 16 h and (C) 
the corresponding cell numbers were counted. (D) HUVEC were treated with different concentrations of calf 
histones, undigested NET (no dig) or completely digested with DNase (3.4 μg/ml DNA-NET) for 16 h, and the 
cytotoxicity was measured. 
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4.11 Histone antibodies reduce NET-induced cytotoxixity   
To investigate whether histones are the cytotoxic part of the NET, different histone antibodies 
were pre-incubated with NET before incubation of NET with epithelial cells. Pre-incubation 
of NET with histone antibodies against DNA/H1, H2A, H2B and H4 but not H3 and 
citrullinated H3 significantly decreased NET-mediated cytotoxicity (Fig. 4.12). These data 
suggest that the cytoxicity of NET is at least partly mediated by histones. 
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Figure 4.12: Histone antibodies decrease NET-induced cytotoxicity of epithelial cells. NET alone or NET 
pre-incuabated with histone antibodies was treated with epithelial cells for 16 h, and cytotoxicity was evaluated. 
Antibodies against DNA/histone H1, H2A, H2B and H4 reduced NET-induced cytoxicity in epithelial cells, 
while antibodies against histone H3, citrullinated H3 (cit H3) and isotype-matched control antibodies (m: 
mouse, rb: rabbit) had no effect on NET-induced cytotoxicity. * P<0.05 and *** P<0.001. 
 
4.12 Activated protein C (APC) decreases epithelial cytotoxicity induced by histones but 
not by NET    
Recently, it was described that APC can decrease histone-mediated cytotoxicity in 
endothelial cell (Xu et al., 2009). Likewise, the cytotoxic activity of purified histones on 
A549 cells was substantially decreased by APC (Fig. 4.13A). In contrast, incubation of NET 
with APC even in high concentrations did not reduce NET-mediated cytotoxicity (Fig. 
4.13B). Moreover, incubation of DNase or undigested forms of NET with APC up to 80 min 
could not decrease NET-mediated cytotoxicity (Fig. 4.13C and D). 
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Figure 4.13:  APC decreases epithelial cytotoxicity induced by histones but not by NET. (A) Calf histones 
(200 and 100 µg/ml) were pre-incubated without or with 100 nM human APC for 1 h at 37ºC and then incubated 
with A549 cells for 16 h to measure LDH release. (B) NET were pre-incubated with APC (protein mass ratio 
APC: NET proteins, 1:5, 1:2 and 1:1) for 1 h at 37ºC and then NET treated with A549 cells for 16 h to measure 
LDH release. APC alone and APC with APC inhibitor (PPACK) were also incubated with A549 cells as 
controls. (C) DNase digested or undigested forms of NET were pre-incubated with 100 nM APC for 20 min to 
80 min before incubation with A549 cells for 16 h to measure LDH release. *** P<0.001.                  
 
4.13 APC degrades histones but not NET-proteins                                           
Similar to what Xu and colleagues showed (Xu et al., 2009), APC can degrade histones (Fig. 
4.14A). However, NET treated with APC did not show any degradation of NET proteins (Fig. 
4.14B, C). Likewise, 2-D fluorescence difference gel electrophoresis (2-D DIGE), which 
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enables accurate analysis of differences in protein abundance between samples, did not show 
any difference between NET treated without or with APC (Fig. 4.14D). 
         
              
               
 
Figure 4.14: APC degrades isolated histones but not NET-associated proteins. (A) SDS-gel electrophoresis  
(15%) of histones and (B) NET proteins without or with incubation with 100 nM APC were carried out, and 
bands were identified with MALDI-TOF-MS. In (A) 10 times higher amount of APC was loaded as a control. 
(C) Two-dimentional (2-D) gel electrophoresis (pI 7-11) of NET (left) and NET treated with APC (right) were 
performed. (D)  NET (Cy3, green) and APC-treated NET (Cy5, red) labeled protein was separated by 2-D gel 
electrophoresis. Gels from both samples were overlaid with a minor space in the vertical orientation (left gel) or 
exactly superimposed (right gel). No difference in the gel profiles was noted. 
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4.14 Polysialic acid (PSA) decreases histones and NET-induced cytotoxicity 
PSA is a large and highly negatively charged glycan that plays essential roles in nervous 
system function and development. Mishra and co-workers have recently shown that histone 
H1 is a binding partner of PSA, and this interaction has a key role for nervous system 
development and regeneration (Mirsha et al., 2010). Based on these findings, the potential 
role of PSA on histone- and NET-induced cytotoxicity was also investigated. PSA was able 
to reduce both histone- and NET-mediated cytotoxicity, even more than histone antibody 
(histone H4 antibody) did; PSA alone did not induce cell death (Fig. 4.15). 
 
Figure 4.15: PSA reduces histones- and NET-mediated epithelial cytotoxicity. Histones or NET pre-
incubated with PSA and histone H4 antibody for 1 h and then incubated with epithelial cells for 16 h to measure 
cytotoxicity. PSA alone had no cytotoxic effect.      
 
4.15 Inhibition of neutrophil elastase does not inhibit NET-induced cytotoxicity    
Another abundant component of NET is neutrophil elastase, which has important roles in 
clearance of invading pathogens (Urban et al., 2009). However, it also mediates neutrophil-
induced tissue damage and degrades extracellular matrix efficiently (Perl et al., 2008). 
Neutrophil elastase in NET showed increase in activity after digestion of DNA either by 
DNase or MNase (Fig. 4.4B and Fig. 4.16A). Neutrophil elastase inhibitor significantly 
inhibited elastase activity in NET (Fig. 4.16A), indicating that neutrophil elastase is active in 
NET and its activity can be abolished by elastase inhibitor. However, elastase inhibitor could 
not reduce NET-mediated cytotoxicity in either digested or undigested NET (Fig. 4.16B).  
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Figure 4.16: Inhibition of neutrophil elastase does not inhibit NET-induced cytotoxicity. (A) Neutrophils 
were stimulated with 50 nM PMA for 4 h or kept unstimulated. The supernatants of the stimulated (Stim) and 
unstimulated (Unstim) cells were collected for elastase activity assay. Moreover, NET were isolated from 
stimulated cells and digested with DNase or MNase or kept undigested. The undigested and digested forms were 
centrifuged and the supernatant were collected for elastase activity assay. Neutrophil elastase activities of the 
samples were measured in the absence (filled bars) or presence (open bars) of neutrophil elastase inhibitor 
(NEI). Elastase concentration for 800 μl supernatant of SN (Ustim), SN (Stim), NET (no dig) and NET (MNase 
or DNase) were 0.07 U/ml, 0.15 U/ml, 0.07 U/ml and 0.33 U/ml, respectively. (B) Cytotoxicity of A549 cells 
was measured after 16 h treatment with NET (DNase-digested) in the absence or presence of NEI. Similar 
results were seen for MNase- or non-digested NET. Differences were considered statistically significant at * 
P<0.05, ** P<0.01, and *** P<0.001. 
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4.16 Inhibition of myeloperoxidase reduces NET-induced cytotoxicity    
One of the other granular components of NET is MPO (Brinkmann et al., 2004; Urban et al., 
2009). MPO has an important role in defence against bacteria, viruses and fungi by 
conversion of hydrogen peroxide to HOCl. However, MPO activity can also induce damage 
to adjacent tissue and, thus, contribute to the pathogenesis of different inflammatory diseases 
including pulmonary injuty (Klebanoff, 1999; Van Der Vliet et al., 2000). Pre-incubation of 
MPO inhibitor with digested or non-digested NET led to reduction of NET-induced 
cytotoxicity in epithelial cells (Fig. 4.17). These data suggest that the cytoxicity of NET is 
partly mediated by MPO.  
 
                                      
 
Figure 4.17: Myeloperoxidase inhibition decreases NET-induced cytotoxicity of epithelial cells. Non-
digested or DNase-digested NET were pre-incubated without or with myeloperoxidase inhibitor (MPOI), 
followed by incubation of NET with epithelial cells (A549) for 16 h. Pre-incubation of NET with  MPOI 
reduced NET-mediated cytotoxicity. MPOI alone (37 ng/ml) was not toxic for the epithelial cells. Differences 
were considered statistically significant at * P<0.05. 
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4.17 NET mediate a biphasic characteristic in epithelial cell permeability 
To scrutinize the effect of NET on epithelial cells, permeability of epithelial cells after 
incubation with NET was measured up to 10 h. Exposure with NET decreased permeability 
of epithelial cells in comparison to the untreated cells in the early phase (up to 6 h), whereas 
an increase in permeability was observed at the later stage (Fig. 4.18). NET digestion by 
DNase did not influence its impact on permeability.   
                                                  
Figure 4.18: NET mediate a biphasic characteristic in the permeability of epithelial cells. Epithelial cells 
were incubated with NET up to 10 h, and cell permeability was evaluated by measuring the flux of trypan blue-
labeled albumin across the cells. Permeability was shown in percentage, where permability in the cells treaed 
only with medium (control) was considered 100%. Decrease in the mean permeability up to approximately 6 h 
and increase at the later time points were noted. Undigested NET: black circle, DNase-digested NET: gray 
square.  
 
4.18 Similarity between supernatant of cystic fibrosis sputum and isolated NET 
Damage in the airways of several lung diseases such as cystic fibrosis is associated with lung 
epithelial cell death, and cystic fibrosis patients have accumulation of extracellular DNA in 
the airways (Hamutcu et al., 2000). In order to investigate the relevance of NET on epithelial 
cell death in cystic fibrosis, sputum from these patients were evalulated for NET formation. 
Patient sputum (without any stimulation) demonstrated NET formation as illustrated by co-
localization of DNA/histone and elastase (Fig. 4.19A) very similar to the appearance of NET 
from isolated neutrophils of healthy human blood that were stimulated with a NET-inducing 
agent such as PMA (Fig. 4.19B). Moreover, sputum supernatant and isolated NET showed 
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very similar structure (Fig. 4.19C and D) which further verifies the presence of NET in cystic 
fibrosis sputum. 
                          
Figure 4.19: Similarity between supernatant of cystic fibrosis sputum and isolated NET. (A) Cystic fibrosis 
sputum and (B) PMA-treated isolated neutrophils from healthy human blood were stained for nucleus (DAPI), 
DNA/histone (red) and neutrophil elastase (NE, green). (C) Co-localization of neutrophil elastase and 
DNA/histone in isolated NET and (D) in the supernatant of cystic fibrosis sputum. 
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5 Discussion 
This study focused on the role of NET in host cell functions, particularly on alveolar 
epithelial cells as major cells responsible for gas exchange in the lung as well as on 
endothelial cells. NET formation in different organisms, its bactericidal activity, and its 
presence in several pathophysiological conditions have been documented; however, little is 
known about the direct effect of NET on host cells and its potential role in inducing ALI. The 
following section will reveal the results of the current thesis and will discuss them in the 
context with the existing literature. 
5.1 Protein identification of NET 
Before investigating the effect of NET on host cells, the proteome profiles of PMA-
stimulated neutrophils and NET proteins were studied. PMA, as a potent inducer of NET, 
was used mostly to induce neutrophils for NET formation. PMA-stimulated neutrophils 
showed upregulation of several proteins in comparison to the unstimulated cells. 
Identification of proteins in NET by mass spectrometry confirmed the presence of different 
kinds of proteins which have been identified by another group (Urban et al., 2009) as well as 
several new proteins (Table 1.1 and 4.1). Besides granular proteins such as MPO, lactoferrin 
and protein S100-A8 and A9, which have antimicrobial activities, the presence of different 
cytoskeletal proteins were further confirmed. Presence of actin and actin binding proteins 
such as profilin-1 or plastin-2 may reflect the role of these proteins for structural organization 
of NET. These proteins may also play important roles in the activity of other cells such as 
platelets or T lymphocytes.  
Glycolytic proteins such as alpha-enolase or glyceraldehyde 3-phosphate dehydrogenase 
were also found in NET. It is appealing to recognize the function of these proteins in NET; 
whether they have a role in glycolysis of the NET-adjacent cells or whether they influence by 
their other activities such as regulation of DNA replication or transcription.  
In addition, some NET-associated proteins, for instance elastase or proteinase-3, with 
antimicrobial functions are capable of degrading the extracellular matrix; which in turn make 
NET more susceptible to induce tissue injury. Interestingly, serpin B1 as an inhibitor of 
proteolysis was also identified in NET which may reveal that even in NET the activity of 
proteases may be regulated in order to prevent the deleterious role of proteases on host tissue.  
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One of the other NET-associated proteins, which was identified for the first time in this 
study, is Annexin A1. Annexin A1 is a calcium/phospholipid-binding protein which has a 
role in membrane aggregation as well as in inhibition of phospholipase A2, and is considered 
as an anti-inflammatory protein by blocking neutrophil trafficking (Perretti and D'Acquisto, 
2009). The presence of this protein in NET implies that NET components not only have 
antimicrobial activities, but they can also regulate inflammation. 
It should be noted that in the present study, due to the practical reasons, not all the NET-
associated proteins were selected for the identification by mass spectrometry. Moreover, from 
the randomly selected protein spots, which were separated by 2-D gel electrophoresis, not all 
could be identified. Investigation of the other NET-associated proteins may uncover the 
effect NET on host cells more precisely. It should also be considered that different 
procedures for NET collection or various techniques for protein identification, such as gel-
free mass spectrometry, may give rise to different results. So far, a standard procedure for 
NET collection, which truly confirms that the isolated NET contain all the materials and 
structures in the in vivo-formed NET, has not been established. Therefore, it is essential to 
mention the exact procedure of NET collection in studies dealing with NET. 
5.2 NET formation in lung tissue and BAL fluid in LPS-induced lung injury model 
Neutrophil products such as ROS, neutrophil elastase, cathepsin-G and other granular 
proteins can damage host cells and tissues and may lead to organ injury if not well-regulated 
(Mizgerd, 2008), and neutrophil-mediated tissue damage at the infected sites is one of the 
major sources that triggers inflammation (Nathan, 2006). Likewise, activated neutrophils 
contribute to lung injury by releasing proteolytic enzymes, ROS and other proinflammatory 
mediators (Lee et al., 2005; Abraham, 2003). 
To investigate the role of NET in ALI, an LPS-induced lung injury model was applied and 
both lung tissue and BAL fluid were examined for NET formation and presence. NET 
formation was observed for neutrophils in BAL fluid and lung tissue after LPS treatment. 
Moreover, activity of neutrophil elastase in BAL fluid was significantly increased after 
digestion of BAL with nuclease in comparison to the secreted elastase. Neutrophil elastase is 
either secreted from granules (free elastase) by activated neutrophils (Mizgerd, 2008; Nathan, 
2006) or it can be expelled together with NET (NET-related elastase) in association with the 
chromatin (Brinkmann, 2004). Visualization of NET in lung tissue and BAL fluid in LPS-
treated mice besides the increase of elastase activity in NET structure after DNA digestion 
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confirmed NET formation in LPS-induced lung injury model. Therefore, besides the key role 
of neutrophils and their secreted proteins, the presence of NET and their associated 
components may serve as additional causal factors which contribute to the pathogenesis of 
ALI and their complications.  
It should be noted that NET formation is not the only activity of neutrophils. Neutrophils can 
damge lung cells by secretion of their components such as granular proteins which may 
further lead to the manifestations of ALI or other lung diseases dealing with epithelial cell 
death. To assure that epithelial cell death is caused only by NET components, the secreted 
materials of neutrophils, which are not in NET structure, should be eliminated. Designing 
such an in vivo model is not possible; therefore, for further experiments the in vitro model 
was performed by incubation of NET collected materials with the epithelial cells.  However, 
whether the in vitro-formed NET have the same components and functions of the in vivo-
formed ones has not been clarified.  
One of the other challenging issues concerning NET detection in the in vivo model is the 
structure of NET in tissues. Immunocytochemistry and NET quantification in the isolated 
neutrophils are quite easy due to the distance between the cells. However, in the tissues such 
as lung when there is not enough space between the cells detection of NET is tricky. Besides, 
presence of short fragments of DNA–protein complexes in the airways as opposed to the long 
stringlike structures seen in ex vivo cultures (Douda et al., 2011), as it has also seen in this 
study, make the detection of NET in tissue much more difficult. 
5.3 The inhibitory role of Eap for NET formation 
NET fornation can be induced by incubation of neutrophils with gram positive and negative 
bacteria as well as fungi and other inflammatory stimuli. It is been also shown that S. aureus 
can induce NET formation (Pilsczek et al., 2010). However, there is no report about the 
effect of bacterial products such as Eap on NET formation. Eap is a secreted protein from S. 
aureus which has a very wide range of binding interactions to host extracellular matrix 
components (Harraghy et al., 2003; Chavakis et al., 2005). Eap has an anti-inflammatory 
function by preventing integrin-dependent neutrophil–endothelial interactions, and S. aureus 
uses this property to escape the host immune system (Chavakis et al., 2002). Interestingly, 
Eap suppressed NET formation in a dose-dependent manner, no matter whether the NET 
inducer was PMA, LPS or NO donor. This characteristic of Eap may be used to regulate NET 
formation.  
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Wang and co-workers have shown that Eap suppresses psoriasis, an inflammatory skin 
disease, by inhibiting T-cell recruitment (Wang et al., 2009). Recently, it has been shown that 
mast cells and neutrophils are the main cell types in human skin that contain IL-17, which is a 
central cytokine to psoriasis pathogenesis. Interestingly, mast cells and neutrophils release 
IL-17 in the process of forming extracellular traps (Lin et al., 2011). Inhibition of NET 
formation by Eap, as it was shown in the present study, may explain one of the mechanisms 
that lead to suppression of psoriasis after Eap administration.  
5.4 The role of NET on host cell cytotoxicity 
It has been reported that excessive NET formation or impairment of NET removal is linked to 
chronic inflammatory diseases such as preeclampsia, small-vessel vasculitis and systemic 
lupus erythematosus (Gupta et al., 2005; Kessenbrock et al., 2009; Hakkim et al., 2010; 
Gupta et al., 2010). Since alveolar epithelial cells are crucial to maintain normal gas 
exchange, and lung epithelial cell death represents a potentially important mechanism 
contributing to the loss of this cell type in the development of ALI (Perl et al., 2008; 
Bachofen and Weibel, 1982), the direct effect of isolated NET on lung epithelial cells was 
further investigated. 
Isolated NET induced cytotoxicity in epithelial cells in a dose-dependent manner. 
Interestingly, DNA alone or DNA-digested NET either completely digested or partially 
digested NET did not change NET-mediated cytotoxicity. Moreover, boiled or denatured 
NET could not induce cytotoxicity which is further an indication that proteins (and not DNA) 
in NET are involved in NET-mediated cytotoxicity of endothelial and lung epithelial cells. 
NET-associated proteins include nuclear and granular proteins as well as cytoplasmic 
proteins such as cytoskeletal and peroxisomal proteins and glycolytic enzymes (Table 1.1 and 
4.1). Most of these NET-associated proteins have high antimicrobial activity. Selective 
antimicrobial peptides differentiate between eukaryotic cells and bacterial cells based on 
variations in the composition of the cell membrane. Since the majority of antimicrobial 
peptides are positively charged at physiological pH, the popular theory is that selectivity 
results from electrostatic attraction of the cationic peptide to the anionic bacterial membranes 
(Zasloff, 2002; Henzler Wildman et al., 2003; Wieprecht et al., 2000; Wiesner and 
Vilcinskas, 2010). However, electrostatic interactions cannot be the only reason for 
selectivity, and other aspects of membrane composition and additional properties of these 
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peptides must also be important in determining selectivity (Dathe and Wieprecht, 1999; 
Henzler Wildman et al., 2003).  
Moreover, specific structures of NET-proteins may be responsible for host cell cytotoxicity. 
There could be unique post-translational modifications of proteins in NET which make them 
cytotoxic. Protein-protein interactions and formation of protein complexes in NET, as shown 
also in the present study by NET fractionation and native-gel electrophoresis, may create 
cytotoxic proteins which can be sensed by death receptors on the host cells.  
Treatment of epithelial cells with NET induced upregulation of different proteins from 
nuclear to membrane proteins with different kinds of functions such as regulation of cell 
cycle, cellular component movement, oxidation-reduction process, cell surface receptor-
linked signaling pathways, glycolysis, lipid metabolic process, regulation of proliferation, 
ubiquitin conjugation and proteosome degradation pathway and interestingly several of these 
proteins are upregulated during cell death and apoptosis (Table 4.2) which  further confirm 
our data about NET-mediated cytotoxicty.  
5.5 The role of histones in NET-mediated cytotoxicity 
Bearing in mind that histones are one of the most abundant components of NET with 
bactericidal and leishmanicidal activity (Brinkmann et al., 2004; Guimarães-Costa et al., 
2009), interference with histones such as histone degradation should decrease NET 
cytotoxicity.  Histones can be degraded with different proteases such as cytotoxic T 
lymphocyte protease granzyme A (Zhang et al., 2001), activated nuclear proteasome (Ullrich 
et al., 1999) or APC. APC is a serine protease which plays an important role as natural anti-
coagulant and also has been reported to degrade histones and thereby reduce cell death in 
sepsis (Xu et al., 2009). While our data showed that APC significantly decreased histone-
mediated epithelial cytotoxicity in a purified system, incubation of NET (either nuclease-
digested or not) with APC could not reduce NET cytotoxicity, although much higher doses of 
APC were used for treatment with NET as in a purified system. Also, DIGE for NET and 
NET incubated with APC, which enables the accurate analysis of differences in protein 
abundance, did not show any difference in the gel profiles. This could be due to the formation 
of histone complexes with DNA or other proteins, to specific modifications of histones in 
NET structure (Urban et al., 2009; Wang et al., 2009), which may protect them against 
degradation by APC, or to the fact that histones are degraded during NET formation 
(Papayannopoulos et al., 2010).  
Discussion 
64                           
As reported before, antibodies against histones can reduce histone-mediated cytotoxicity 
during sepsis (Xu et al., 2009). Likewise, pre-treatment of NET with different antibodies 
against histones could decrease NET-mediated cytotoxicity; however, it was not effective for 
all kinds of histones. Specific modification(s), unique structures of histones, histone 
degradation during NET formation or the protein complexes in NET could be responsible for 
such differences. Xu and colleagues mentioned that antibodies against histones had better 
effect in comparison with APC to reduce histone-mediated cytotoxicity, at least because of 
the bleeding complications which might occur by using APC (Xu et al., 2009). Although they 
induced sepsis by purifed histones, further recruitment of neutrophils and NET formation 
cannot be ignored. NET may lead to further cell death and this might be one of the reasons 
that explain why antibodies against histones were more effective than APC for treatment of 
sepsis. 
The antimicrobial activity of histones has been discovered more than half a century ago. Final 
concentrations of less than 1 µg/ml histone kill susceptible microbes without detectable 
morphological alteration or lysis. However, among the microorganisms some are highly 
susceptible to histone, some are less and some are resistant to histones. The bactericidal effect 
of histone is antagonized by small amounts of certain basic substances (protamine, spermine), 
or by various acid polysaccharides (heparin, nucleic acids, bacterial lipopolysaccharides) 
(Hirsch, 1958). The present study also showed that pre-incubation of histones or NET with 
PSA showed decrease in histone- and NET-mediated cytotoxicity, respectively. PSA is a 
highly negatively charged glycan that binds to histone H1 and this interaction has a key role 
for nervous system development and regeneration. Histone H1 promotes axon outgrowth of 
cerebellar neurons in a PSA-dependent manner (Mirsha et al., 2010). The present data may 
indicate that histones interact specifically with certain molecules on the host cell membrane 
and induction of cytotoxicity by histones is not unspecific. However, PSA, as a negatively 
charged molecule, may also neutralize the positive charge of antimicrobial peptides in NET, 
and lead to reduction in cytotoxicity. Further studies on the role of PSA in histone- and NET-
mediated cytotoxicity are under investigation. 
Moreover, histones can influence cell permeability (Zhdan-Pushkina et al., 1975), and 
prolonged exposure of the epithelium to histone proteins causes irreversible loss of 
transepithelial resistance (Kleine et al., 1995). The present data showed that NET induced a 
biphasic characteristic in epithelial cell permeability; a decrease in permeability at earlier 
time points and an increase at the later stage of NET incubation was observed. NET proteins 
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including histones may have a major role in this process. These proteins may be sensed by 
various response signals in bystander cells depending on the time and amount of NET 
exposure. 
5.6 The role of non-histone components of NET in NET-mediated cytotoxicity 
Besides histones, another abundant component of NET is neutrophil elastase (Urban et al., 
2009), which has an important role in clearing invading pathogens. Moreover, elastase is able 
to mediate neutrophil-induced tissue damage and can degrade extracellular matrix efficiently 
(Perl et al., 2008). Neutrophil elastase activity in NET increased after digestion of DNA. 
These data support the presence of NET in BAL fluid after LPS induction, as they also 
showed increase in elastase activity after DNA digestion. However, inhibition of neutrophil 
elastase in DNase-digested or non-digested NET did not reduce NET-mediated cytotoxicity. 
Presence of more cytotoxic components of NET (such as histones) can explain this effect so 
that inhibition of neutrophil elastase is not sufficient to suppress NET-mediated cytotoxicity.  
MPO, another granular protein with anti-microbial activity, was also investigated for NET-
mediated cytotoxicity in the present study. MPO has an important role in defence against 
bacteria by conversion of hydrogen peroxide to HOCl. Nevertheless, MPO activity can also 
provoke damage to adjacent tissue and, therefore contribute to the pathogenesis of several 
inflammatory diseases including pulmonary injuty (Klebanoff, 1999; Van Der Vliet et al., 
2000). It has been reported that MPO can provoke caspase-3 activation and apoptosis in HL-
60 human leukemia cells (Myzak and Carr, 2002). Moreover, MPO can induce DNA strand 
breakage in lung epithelial cells (Haegens et al., 2008). Pre-incubation of NET with MPO 
inhibitor decreased NET-mediated cytotoxicity of epithelial cells, indicating that besides 
histones MPO is also responsible for the cell damaging capacity of NET. 
More than twenty different proteins have been identified in NET (Table 1.1 and 4.1), and 
investigation of all of these proteins on NET-mediated cytotoxicity is beyond the scope of the 
present study. It should be considered that not always the quantity but also the quality of NET 
components may have an important role in inducing cytotoxicity. The proteins (identified or 
non-identified) which encompass only a small quantity of NET components maybe even 
more toxic for the host cells in comparison to the other proteins. The diversity of NET 
proteins and their incomplete identification make the recognition and analysis of the 
cytotoxic parts of NET more complicated.  
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5.7 The pathophysiological role of NET   
NET has been seen in different pathophysiological situations including appendicitis 
(Brinkmann et al., 2004), severe sepsis (Clark et al., 2007), autoinflammatory disorders such 
as small-vessel vasculitis (Kessenbrock et al., 2009), systemic lupus erythematosis (Hakkim 
et al., 2010), Crohns disease (Yousefi et al., 2008) and in vein thrombosis (Fuchs et al., 
2010). All of these examples show a potential proinflammatory role of NET. 
Many lung diseases, including ALI, fibrosis or cystic fibrosis are associated with the lung 
epithelial cell death. Progressive infection and inflammation in the lower airways results in 
destruction of the small and medium airways in the lung in cystic fibrosis patients, and in 
these patients, extracellular DNA accumulates in the airway due to the chronic bacterial 
infection (Hamutcu et al., 2002). In the present study, the structural similarity between 
isolated NET and the supernatant of cystic fibrosis sputum has been observed. Moreover, 
immunocytochemistry of patients sputum showed structures similar to NET; chromatin fibers 
decorated with granular proteins. Although the use of aerosol recombinant human DNase 
therapy is linked with an improvement in airflow obstruction and a decrease in the number of 
infectious respiratory exacerbations in some cystic fibrosis patients, this is not true for all 
cases (Fuchs et al., 1994). It was seen that even the digestion of DNA in NET could not 
abolish NET cytotoxicity, and maybe this is one of the reasons that DNase therapy is not 
useful in all cystic fibrosis patients. Presence of NET in high amount in these patients may be 
one of the reasons which lead to pulmonary obstruction. Since cystic fibrosis sputum contains 
various cells and compounds, and handling the muocus sputum usually needs further 
treatments such as DTT-treatment, incubation of cystic fibrosis sputum with epithelial cells 
was not practical.  
In this study, the direct effect of NET on endothelial and lung epithelial cells has been 
examined. However, the in vivo situation is far more complex. Phagocytosing cells remove 
dead cells and their debris (maybe NET too). Furthermore, the ciliary motion in the lung 
prevents staying of dead cells for a long time in one place. It has to be further investigated 
whether one of the reasons which promote lung destruction in patients with ALI or cystic 
fibrosis is impairment in the clearing mechanisms of NET.  
It is also worthwhile to consider the variation of responses to NET in different individuals. 
Some individuals may produce the same amount of NET as others; however, they may have 
defect in resolution and removing the NET components. In contrast, others may have normal 
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resolution systems but they produce more NET. All of these aspects should be considered 
before designing any therapeutic agent for patients who suffer from complications of NET 
formation. It is also crucial to know where exactly in the tissues NET will form, and how a 
potential drug can reach NET.  
5.8 Conclusion and further directions 
Taken together, the results of the present study demonstrate that NET induce cytotoxicity in 
endothelial and lung epithelial cells in a dose-dependent manner and the type of DNA 
digestion in NET (either digested or not) does not influence NET-mediated cytotoxicity.  
In addition to the results represented here, other components of NET may be responsible for 
NET-mediated cytotoxicity. Investigation of the protein components in NET, their unique 
structures and the possible receptors which sense NET will be useful to design therapeutic 
agents for the people who suffer from impairment of NET and its complications. Proteins 
such as Eap, which inhibits NET formation, histone antibodies or negatively charged glycan 
such as PSA, which decrease NET-mediated cytotoxicity, are some potential candidates that 
can be considered to decrease the deleterious effects of NET.  
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